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ABSTRACT
ENCAPSULATION OF PROBIOTIC MICROORGANISMS IN FOOD-GRADE
HYDROGEL MICROBEADS FOR IMPROVING LONG-TERM STORAGE AND
ORAL DELIVERY
SEPTEMBER 2016
TIMOTHY W. YEUNG, B.S., PENNSYLVANIA STATE UNIVERSITY
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: David A. Sela

Probiotics die over time during processing, storage and digestion, resulting in reduced
health benefits to the consumer. Microencapsulation of microorganisms is an effective
way to improve probiotic viability by restricting cell exposure to extreme conditions
through the gastrointestinal tract until release in the colon. In this work, appearance and
survival of encapsulated probiotic species from two genera was explored. Lactococcus
lactis and Bifidobacterium longum were suspended in calcium alginate microbeads by
spraying droplets of alginate-probiotic mixture into calcium chloride solution. This
produced uniformly shaped transparent microbeads with high encapsulation yield.
Encapsulating Lactococcus lactis extended viability during dry room temperature storage.
Encapsulating Bifidobacterium longum revealed high variation between eight different
strains from subspecies longum and infantis. Coating alginate particles with chitosan did
not improve viability and, viability of free and encapsulated bifidobacteria decreased
when exposed to simulated gastric and intestinal conditions. Data from these studies
suggest microencapsulating probiotic cells is an invaluable process to extending cell
viability. Future research should optimize current formulations to improve encapsulation
yield and cell survival during processing, storage, and gastrointestinal transit.
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TABLE OF CONTENTS
Page
ACKNOWLEDGMENTS ...................................................................................................v
ABSTRACT ....................................................................................................................... vi
LIST OF TABLES ............................................................................................................. ix
LIST OF FIGURES .............................................................................................................x
CHAPTER
1. LITERATURE REVIEW ..............................................................................................1
1.1 Introduction ........................................................................................................1
1.2 Probiotics ...........................................................................................................2
1.3 Microencapsulation ............................................................................................3
1.4 OBJECTIVES ..................................................................................................10
2. MICROENCAPSULATION OF PROBIOTICS IN HYDROGEL PARTICLES:
ENHANCING LACTOCOCCUS LACTIS SUBSP. CREMORIS LM0230
VIABILITY USING CALCIUM ALGINATE BEADS .............................................11
2.1 Abstract ............................................................................................................12
2.2 Introduction ......................................................................................................13
2.3 Materials and methods .....................................................................................16
2.4 Results ..............................................................................................................19
2.5 Discussion ........................................................................................................25
2.6 Acknowledgements ..........................................................................................29
3. MICROENCAPSULATION IN ALGINATE AND CHITOSAN MICROGELS
TO ENHANCE VIABILITY OF BIFIDOBACTERIUM LONGUM FOR ORAL
DELIVERY..................................................................................................................30
3.1 Abstract ............................................................................................................31
3.2 Introduction ......................................................................................................32
vii

Page
3.3 Materials and methods .....................................................................................34
3.4 Results ..............................................................................................................42
3.5 Discussion ........................................................................................................52
3.6 Acknowledgements ..........................................................................................55
4. CONCLUSION ............................................................................................................56
APPENDICES
A: SUPPLEMENTAL DATA ...............................................................................57
B: EXTENDING VIABILITY OF LACTOBACILLUS PLANTARUM AND
LACTOBACILLUS JOHNSONII BY MICROENCAPSULATION IN
ALGINATE MICROGELS .............................................................................61
BIBLIOGRAPHY ..............................................................................................................75

viii

LIST OF TABLES

Table

Page

2.1 Mean particle diameters of alginate beads prepared with and without Lactococcus
lactis LM0230 cells for two gelation time periods ......................................................20
3.1 Bifidobacterium longum strains selected for encapsulation.........................................35
3.2 Mean particle diameters of alginate and chitosan-coated alginate beads containing
strains of Bifidobacterium longum ...............................................................................42
3.3 Zeta potential of alginate and chitosan-coated alginate beads containing strains of
Bifidobacterium longum...............................................................................................46
3.4 Survival of free and encapsulated Bifidobacterium longum subsp. infantis
UMA 299 in three separate simulated digestion phases ..............................................52
A.1 Survival of Lactococcus lactis subjected to drying at room temperature
(22-25°C) .....................................................................................................................57
A.2 Viability of free Bifidobacterium longum cells during refrigerated storage ...............58
A.3 Viability of Bifidobacterium longum cells encapsulated in calcium alginate
during refrigerated storage ...........................................................................................59
A.4 Viability of Bifidobacterium longum cells encapsulated in chitosan-coated
alginate during refrigerated storage .............................................................................60
B.1 Mean particle diameters of alginate beads containing Lactobacillus plantarum
and Lactobacillus johnsonii .........................................................................................68
B.2 Viability of free and encapsulated Lactobacillus plantarum and Lactobacillus
johnsonii during refrigerated storage ...........................................................................72
B.3 Simulated digestion of free and encapsulated Lactobacillus plantarum and
Lactobacillus johnsonii cells........................................................................................73

ix

LIST OF FIGURES

Figure

Page

1.1 Experimental design for immobilizing probiotics in alginate microbeads ....................8
2.1 Particle size distribution of alginate beads prepared with and without Lactococcus
lactis LM0230 cells for two gelation time periods ......................................................21
2.2 Optical microscope images of (A) Lactococcus lactis LM0230 (40×), (B) unfilled
alginate microbead (40×), and filled alginate beads gelled for (C) 1 hour (40×)
and (D) 24 hours (40×) ................................................................................................22
2.3 Scanning electron microscope images of (A) Lactococcus lactis LM0230 (5000×),
(B) unfilled alginate microbead (500×), and filled alginate beads gelled for (C) 1
hour (400×) and (D) 24 hours (1100×) ........................................................................23
2.4 Confocal microscope images of (A) Lactococcus lactis LM0230, (B) unfilled
alginate microbead, and (C) filled alginate beads ........................................................24
2.5 Survival of free and encapsulated Lactococcus lactis LM0230 in calcium alginate
beads during dry room temperature storage.................................................................25
3.1 Experimental design for simulated digestion of free and encapsulated
Bifidobacterium longum subsp. infantis UMA 299 .....................................................41
3.2 Optical microscope images of (A) Bifidobacterium longum subsp. infantis
UMA 300 (20×), (B) unfilled alginate bead (20×), (C) filled alginate bead with B.
longum UMA 306 (20×), (D) B. longum subsp. longum UMA 318 (20×),
(E) unfilled chitosan-coated alginate bead (20×), and (F) filled chitosan-coated
alginate bead with B. infantis UMA 299 (20×) ...........................................................44
3.3 Scanning electron microscope images of (A) Bifidobacterium longum subsp.
infantis UMA299, (B) unfilled alginate bead, (C) unfilled chitosan-coated
alginate bead, (D) B. longum subsp. longum UMA 306, (E) alginate bead
containing B. longum subsp. longum UMA 401, and (F) chitosan-coated alginate
bead containing B. longum subsp. infantis UMA 300 .................................................45
3.4 Survival of free Bifidobacterium longum cells in wet refrigerated storage over
time ..............................................................................................................................47
3.5 Survival of Bifidobacterium longum cells in calcium alginate microbeads in wet
refrigerated storage over time ......................................................................................49
3.6 Survival of Bifidobacterium longum cells in chitosan-coated alginate microbeads
in wet refrigerated storage over time ...........................................................................50

x

B.1 Particle size distribution of alginate beads containing Lactobacillus plantarum
and Lactobacillus johnsonii .........................................................................................68
B.2 Optical microscope images of (A) alginate microbead containing Lactobacillus
plantarum (20×), (B) alginate microbead containing Lactobacillus johnsonii
(20×).............................................................................................................................69
B.3 Scanning electron microscope images of (A) Lactobacillus plantarum
ATCC BAA-793 (4000×), (B) alginate bead containing L. plantarum (300×),
(C) Lactobacillus johnsonii ATCC 33200 (2000×), (D) alginate bead containing
L. johnsonii (500×) ......................................................................................................70
B.4 Survival of free and encapsulated Lactobacillus plantarum and Lactobacillus
johnsonii during refrigerated storage ...........................................................................71

xi

CHAPTER 1
LITERATURE REVIEW
1.1

Introduction
Scientific understanding of probiotics has been developing ever since the term

was introduced by Lilly and Stillwell (1965). Put simply, probiotics are microorganisms
that confer health benefits on the consumer host, particularly associated with the
gastrointestinal (GI) tract. Current technical definitions of the term probiotic emphasize
the viability and concentration of microorganisms needed for the consumer to gain health
benefits (Schrezenmeir and de Vrese, 2001). Benefits from probiotics include modulating
inflammatory response in the colon, strengthening the immune system, preventing growth
of pathogens, and improving nutrient absorption (Lian et al., 2003; Parvez et al., 2006;
Anal and Singh, 2007). While probiotic consumption in function foods and supplements
have become increasingly popular, studies on their efficacy need to be established.
Major criteria for determining efficacy include proper identification of strains
used by the consumer, viability of those strains at the time of consumption, and consistent
quality of the product (Lewis et al., 2015). A minimum of 106 - 108 CFU/mL present in
the consumed product is the recommended concentration to be effective (Krasaekoopt et
al., 2003; Amine et al., 2014b). This concentration is initially added as free cells into
fermented products, but overall viability degrades during storage. While conventional
methods add free cells several log CFU higher than the suggested dose, intrinsic factors
of the food product such as low pH, low water activity, and presence of antibiotic
substances can accelerate decline of probiotic viability below the recommended dose
(Rokka and Rantamäki, 2010). Free cells are also exposed to extreme conditions during
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digestion. Low pH in the gastric phase and potent enzymes throughout the GIT can cause
significant loss of cell viability. As few as 20-40% log CFU probiotic cells can survive
gastrointestinal transit, depending on the species and strain (Bezkorovainy, 2001). Thus,
processing methods to mitigate degradation of cell viability are necessary to impart health
benefits despite long storage periods as well as gastrointestinal transit.
1.2

Probiotic bacteria
Several diverse groups of microorganisms are considered probiotic with a wide

range of health benefits. The two major groups are lactic acid bacteria and bifidobacteria.
Lactic acid bacteria (LAB) are a large group of Gram positive microorganisms found in a
diverse range of environments. Several genera within this group include Enterococcus,
Lactobacillus, Lactococcus, Leuconostoc, Oenococcus, Pediococcus, and Streptococcus
and are associated with the surfaces of vegetation and dairy products. LAB all have the
ability to produce lactic acid as an end product, and are often used for fermentative
processes (Price et al., 2012). As a result, many LAB have high acid tolerance, allowing
them to survive gastrointestinal transit, colonize the host colon and, outcompete growth
of pathogens. This group is highly diverse, producing many different end-products other
than lactic acid, which affect flavor profiles of the food products they are added into.
While many species within this group are considered spoilage organisms, others are
generally recognized as safe (GRAS) and are used to ferment food products such as
cheeses, yogurt, and sauerkraut.
Bifidobacteria are a smaller group of anaerobic Gram positive bacteria closely
associated with the mammalian gut. Most species within this group are considered
probiotic, breaking down a wide variety of indigestible carbohydrates (Chaplin et al.,
2

2015). Bifidobacteria may even have a role in establishing host gut microbiome shortly
after birth (Sela and Mills, 2010). Like LAB, bifidobacteria produce lactic acid. Presence
of oxygen can cause irreparable oxidative damage to bifidobacteria, depending on their
aerotolerance. Some species like B. animalis are faculatative, while others like B. longum
are strictly anaerobic. However, B. longum has been found to colonize the infant gut
more effectively than B. animalis (Underwood et al., 2013). Preparation techniques need
to be adapted to minimize oxygen permeability during storage as supplements or within
food products (O'Riordan et al., 2001). Acid resistance of bifidobacteria is strain
dependent. B. longum and B. bifidum strains was shown to be more sensitive to highly
acidic (pH 2) conditions than B. lactis, B. breve, and B. adolescentis strains (Hansen et
al., 2002). However, B. longum and B. breve strains were less sensitive than B. bifidum
and B. adolescentis strains when exposed long term to more alkaline (pH 4) conditions
(Sun and Griffiths, 2000).
Other probiotics include certain bacterial strains of E. coli and Bacillus
coagulans. Most fungi are not probiotic, with possible exceptions of a few
Saccharomyces species which are facultative anaerobes. Novel probiotic strains and
combinations of these strains continue to be discovered and evaluated for human
consumption and other agricultural applications (Fernández-Murga and Sanz, 2016; Neau
et al., 2016; Salvetti et al., 2016).
1.3

Microencapsulation
Encapsulation is a way to protect bacteria against severe environmental factors by

suspending cells within hydrogel particles bacteria will survive during processing and
storage (Anal and Singh, 2007; Champagne and Fustier, 2007). Providing live probiotic
3

cells with a physical barrier is an increasingly popular approach to protecting them from
adverse conditions within the product and during digestion (Kailasapathy, 2009). This
process can be physicochemical and/or mechanical in order to entrap an agent in a
material resulting in the production of particles ranging from 1-1000 µm, which isolate
them and delay their release.
Several reviews have thoroughly catalogued studies examining the effects of
encapsulating probiotics, classifying them based on probiotic species, encapsulation
materials, and processing methods utilized (Krasaekoopt et al., 2003; Rokka and
Rantamäki, 2010; Chávarri et al., 2012; Solanki et al., 2013). Studies have commonly
reported variability in responses to growth or stability between strains (Godward, 2000;
Krasaekoopt, 2004; Capela et al., 2006; Ranadheera et al., 2010). Therefore, in order to
describe the effect of encapsulation techniques on probiotic bacteria viability, it is
desirable to select cultures that are sensitive to various environmental stresses. In
addition, one problem associated with microencapsulated cultures for foods is their effect
on sensory properties (Karimi, 2011). Particle size and cellular stress are important
factors of encapsulation technologies which can impact texture and taste perception
(Hansen et al., 2002; Burgain et al., 2011). There is interest in comparing different
encapsulation technologies in order to improve the utilization of beneficial probiotics
microorganisms in the food industry.
The most important factors influencing the efficiency and acceptability of
encapsulation include starting materials used to encapsulate probiotic cells, the
encapsulation processing method employed, and particle size resulting from processing.
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1.3.1

Materials used for microencapsulation
A wide range of food-grade polymers have been used for encapsulating probiotic

cells: starch, pectin, cellulose, gelatin, alginate, chitosan, gums like guar, gellan, and
carrageenan, and composites of these (Kosaraju, 2005; Prakash et al., 2011; Sarao and M,
2015). Probiotics can be encapsulated by simply suspending cells within hydrogel
particles made of one or more polymers or suspending cells within complex multi-layered
hydrogel particles. The latter method typically requires gelling the internal encapsulation
followed by coating the particles with a secondary (and even tertiary) layer (Sarao et al.,
2015). Multi-layered encapsulation is favorable, because each polymer has its limitations
in terms of stability. Gums like carrageenan require increased temperature to induce
gelation (Anal and Singh, 2007). Starch cannot form beads alone, and requires chemical
modification (Rokka and Rantamäki, 2010). Chitosan dissolves in low pH, releasing its
content before reaching the colon (Kosaraju, 2005). Alginate, the most commonly used to
encapsulate probiotics, requires calcium ions to form a gel matrix around core material
via cross-linking (Kailasapathy, 2002; Kosaraju, 2005). Several studies suggested that
encapsulating probiotics with alginate coated with chitosan allowed better viability than
encapsulating with alginate alone (Lee et al., 2004; Iyer and Kailasapathy, 2005;
Kamalian et al., 2014). Chemical modification of polymers can also improve
encapsulation functionality. Encapsulating Bifidobacterium longum with N-palmitoylated
alginate has previously shown to increase encapsulation yield compared to encapsulating
with native alginate (Amine et al., 2014b). Encapsulation with modified starch may slow
coating solvation in the upper GI tract and additionally give prebiotic effect to gut
microflora (Kosaraju, 2005).
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A synbiotic preparation, that is co-encapsulation of probiotics with prebiotics, is
thought to enhance cell viability by strengthening the hydrogel structure and/or
improving the fitness of the microbial cells. An in vitro study found that Lactobacillus
acidophilus strains encapsulated with high amylose corn starch significantly increase
viability counts during acidification (Sultana et al., 2000). Another in vitro study
supported previous results of encapsulation with starch. L. acidophilus with prebiotics
inulin and oligofructose also enhanced viability, but not as much as the corn starch. The
authors suggest that the 1.0% (w/v) starch granules blocked pores in the polymer matrix,
restricting cell exposure to low pH. However, interaction of the encapsulation material
with prebiotics may also hinder capsule integrity, depending on prebiotic concentration
(Iyer and Kailasapathy, 2005). Fritzen-Freire et al. (2012) did a similar study
encapsulating Bifidobacterium BB-12 in reconstituted skim milk mixed with inulin or
oligofructose. Microbeads with oligofructose-enriched inulin and microbeads with
oligofructose protected bifidobacteria better than other samples during storage.
Several studies suggested that chitosan with alginate allowed better viability than
alginate alone (Krasaekoopt, 2004; Lee et al., 2004; Iyer and Kailasapathy, 2005).
Incorporating modified polymers can affect encapsulation functionality. Beads containing
B. longum sp. made with N-palmitoylated alginate have higher encapsulation yield than
that made with native alginate (Amine et al., 2014b). Encapsulation with modified starch
may slow coating solvation in the upper GI tract and give prebiotic effect to gut
microflora (Kosaraju, 2005).
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1.3.2

Processing methods of encapsulation
Several methods exist for microencapsulation production, but the most common

techniques are spray drying, extrusion, and emulsion (Rokka and Rantamäki, 2010).
Spray drying involves atomizing solution containing core material (i.e. probiotic cells)
and polymer into a heated chamber, leaving dried beads of encapsulated material
(Chávarri et al., 2012; Solanki et al., 2013). Spray-drying is an inexpensive process
widely used on the industrial scale. However, high temperature and desiccation cause
initial cell population to decrease (Kailasapathy, 2002; Rokka and Rantamäki, 2010).
Encapsulation materials used in this process are also limited to prevent sticking to the
collection vessel. Nonetheless this technology can be applied to heat-tolerant probiotic
strains. O'Riordan et al. (2001) studied the heat effect of spray drying Bifidobacterium
PL-1 in starch. More cells survived processing in comparison to free cells. This suggests
that starch had a protective effect on the encapsulated cells. It was suggested that air
temperature of 100°C was best to minimize cell death to less than 1 log, while producing
dry microbeads. However, less than one-third of the cells could be recovered using such
conditions (O'Riordan et al., 2001).
The oldest method of microencapsulation, extrusion technique, involves pumping
a core material-polymer solution (typically alginate) through a syringe or microfluidics
system into a hardening solution (calcium ions), resulting on hydrated hydrogel
microparticles (Figure 1.1). Technology employing this method has been further
developed to optimize consistency and speed at which wet particles can be produced
(Brandenberger et al., 1999; Whelehan and Marison, 2011; Seiffert, 2013). Extrusion
encapsulation is also inexpensive, but typically used to produce hydrogel particles larger
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particle sizes above 1 mm, which can affect sensory perception if added into food
products (Rokka and Rantamäki, 2010; Solanki et al., 2013). This is generally controlled
by nozzle size and concentration of polymer solution, but viscosity limits these
adjustments.

Figure 1.1: Experimental design for immobilizing probiotics in alginate
microbeads. (A) An isolated colony of probiotic cell culture is obtained. (B) The isolate
is inoculated into growth media and incubated at set temperature. The growth is then
centrifuged, and re-suspended to appropriate concentration. (C) The cell suspension is
dispersed in sodium alginate solution prior to extrusion. (D) Droplets of cell-polymer
solution are sprayed into cross-linking solution, forming hydrogel microbeads. (E) The
microbeads are filtered and rinsed before storage.

As its name suggests, emulsion-based encapsulation involves emulsifying core
material – polymer solution in a lipid base followed by breaking the emulsion by adding
a hydrophilic hardening solution. The beads are subsequently filtered out and washed to
remove residual oils (Sheu and Marshall, 1993; Kailasapathy, 2002). This method
produces smaller sized particles and can be scaled up, but overall size distribution tends
to be high and processing is more costly due to the use of oils and surfactants (Chávarri et
al., 2012; Solanki et al., 2013). Residual oil on the microencapsulation particles may also
affect nutritional composition and oxidative stability of food products (Kailasapathy,
2002).
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1.3.3

Encapsulation particle size
Particle size distribution of microencapsulated beads can affect physical and

biochemical acceptability of product. Hansen et al. (2002) encapsulated various
Bifidobacterium sp. in alginate and exposed them to GI conditions. They observed that
alginate beads 1 mm in diameter were unsuitable for incorporation in milk, adversely
affecting mouth feel. The ideal size for particles containg probiotics was suggested be
around <100 µm in diameter, small enough to minimize texture change and large enough
to effectively protect immobilized cells (McMaster and Kokott, 2005; Martín et al.,
2015).
Cell metabolism may be altered by particle size which influences diffusion of
external factors into the beads. Because of this, off-flavors or other compounds which are
atypical of products which use free cells. Hansen et al. (2002) found that yogurt
containing encapsulated cells tasted more bitter than yogurt prepared with free cells; they
thought that peptide production by the probiotics was the cause. Although this
observation has been noted in sensory tests of microbeads in foods, little research has
critically analyzed the metabolic change of encapsulated bifidobacteria which results in
altered sensory perception (Karimi, 2011). Particle size and cellular stress are important
factors of encapsulation technologies which can impact texture and taste perception
(Hansen et al., 2002; Burgain et al., 2011).
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1.4

Objectives

The purpose of this research was to establish a standardized encapsulation method to
compare the survival of free and encapsulated probiotic bacteria during storage and
simulated digestion.

The objectives were as follows:
1. Track viability of free and encapsulated Lactococcus lactis during storage in room
temperature conditions.
2. Evaluate variation in survival between several strains of free and encapsulated
Bifidobacterium longum subsp. infantis and Bifidobacterium longum subsp.
longum during refrigerated storage and in simulated digestion phases.
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CHAPTER 2
MICROENCAPSULATION OF PROBIOTICS IN HYDROGEL PARTICLES:
ENHANCING LACTOCOCCUS LACTIS SUBSP. CREMORIS LM0230
VIABILITY USING CALCIUM ALGINATE BEADS

Published in:
Yeung, T.W., Arroyo-Maya, I.J., McClements, D.J., and Sela, D.A. (2016).
Microencapsulation of probiotics in hydrogel particles: enhancing Lactococcus lactis
subsp. cremoris LM0230 viability using calcium alginate beads. Food & Function 7(4),
1797-1804. doi: 10.1039/C5FO00801H.
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2.1

Abstract
Probiotics are beneficial microbes often added to food products to enhance the health

and wellness of consumers. A major limitation to producing efficacious functional foods
containing probiotic cells is their tendency to lose viability during storage and
gastrointestinal transit. In this study, the impact of encapsulating probiotics within foodgrade hydrogel particles to mitigate sensitivity to environmental stresses was examined.
Confocal fluorescence microscopy confirmed that Lactococcus lactis were trapped within
calcium alginate beads formed by dripping a probiotic-alginate mixture into a calcium
solution. Encapsulation improved the viability of the probiotics during aerobic storage:
After seven days, less than a two-log reduction was observed in encapsulated cells stored
at room temperature, demonstrating that a high concentration of cells survived relative to
non-encapsulated bacteria. These hydrogel beads may have applications for improving
the stability and efficacy of probiotics in functional foods.
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2.2

Introduction
Lactococcus lactis are members of the polyphyletic clade of microorganisms

referred collectively as the lactic acid bacteria. L. lactis are Gram-positive, low G+C, acid
tolerant, non-spore-forming cocci that are often employed in dairy fermentations and are
naturally associated with plants (Stark and Sherman, 1935; Price et al., 2012). In addition
to food fermentations, L. lactis has been employed as a delivery vehicle to secrete
interleukin-10 in situ in order to reduce colitis in murine (Steidler et al., 2000), porcine
(Steidler et al., 2003), and human subjects (Braat et al., 2006). In addition, L. lactis has
been demonstrated as a versatile platform to deliver vaccines to mucosal tissues (Ramirez
et al., 2010). Despite their utility as a genetically malleable delivery vehicle, L. lactis is
not a typical resident of the human gut microbiome and is confronted with a variety of
physicochemical, enzymatic, and biological hurdles while transiting the gastrointestinal
tract (GIT). As a consequence, there is typically a major reduction in the number of
viable cells reaching the colon after oral ingestion.
In the food industry, probiotic bacteria are often incorporated into functional food
or beverage products. To exert their beneficial health effects, the probiotics must remain
sufficiently viable throughout the manufacture, transport and storage of a product, as well
as during passage through the relatively harsh environment of the GIT. Several studies
have previously shown that probiotic preparations containing free cells are highly
vulnerable to degradation within food products and during passage through the GIT
(Sheu and Marshall, 1993; Sultana et al., 2000; Sun and Griffiths, 2000; de Vos et al.,
2010). The required dose of probiotics depends on the bacterial strain and the food
application (Sanders, 2008), but relatively high concentrations are sought (e.g. 106-108
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CFU/g) (Ouwehand and Salminen, 1998; Krasaekoopt et al., 2003; Talwalkar and
Kailasapathy, 2003; Roy, 2005). The high susceptibility of probiotics to degradation
means that effective encapsulation strategies are required to protect them within foods
and the upper GIT, but then release them within the colon where they can exert their
beneficial effects.
Numerous approaches can be used to encapsulate probiotics based on different
physicochemical and mechanical methods (Kailasapathy, 2002; Anal and Singh, 2007;
Rokka and Rantamäki, 2010). Extrusion encapsulation is one of the most simple and
effective methods of encapsulation probiotics (Krasaekoopt et al., 2003). This approach
usually involves encapsulating bacterial cells within hydrogel particles fabricated from
food-grade biopolymers (Kosaraju, 2005). The probiotic-loaded hydrogel particles are
formed using a number of steps: (i) the probiotic bacteria are dispersed within an aqueous
biopolymer solution that is capable of being gelled: (ii) this mixture is extruded into a
gelling environment through a small nozzle to form small biopolymer droplets with
bacteria inside; (iii) the biopolymer droplets are then stabilized against dissociation or
aggregation using gelation and/or coating methods. The resulting hydrogel particles can
then be collected, washed, and dried. This process produces a powdered form of the
probiotic cells that can be conveniently incorporated into functional foods (Conway et al.,
2001; Lian et al., 2003; Oliveira et al., 2007), while maintaining the viability of the
bacterial cells (Trindade, 2000; Favaro-Trindade and Grosso, 2002; Baur and Sinclair,
2006; Liserre et al., 2007; Oliveira et al., 2007; Shima et al., 2009; Thantsha et al., 2009).
If the biopolymers used are indigestible within the upper GIT (i.e., dietary fibers) and
maintain their physical integrity, then the hydrogel particles may retain and protect the
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bacteria until they reach the colon where they are released when the biopolymer matrix is
digested by colonic bacteria. Few encapsulation studies have specifically investigated L.
lactis as its probiotic function may best lie in its ability to deliver heterologous bioactive
molecules in situ rather than direct interactions with microbiota or their host (Champagne
et al., 1992; Morin et al., 1992; Groboillot et al., 1993; Hyndman et al., 1993;
Klinkenberg et al., 2001; Divya and Nampoothiri, 2015). Thus the lactococcal cell
represents the primary vehicle with the single-layer biopolymer encapsulant the
secondary shield.
Alginate is one of the most widely used food-grade biopolymers for encapsulation
purposes as it is a naturally-occurring polysaccharide that is non-toxic to both probiotic
cells and humans (Gudmund, 2006; Quignard et al., 2008)). Moreover, alginate forms
hydrogel matrices around bacterial cells using mild processing conditions that promote
cellular integrity (Morin et al., 1992; Zhou et al., 1998; Divya and Nampoothiri, 2015).
Typically, the bacteria are mixed with an alginate solution that is then injected into an
aqueous calcium solution, which leads to the formation of probiotic-loaded calcium
alginate beads. In this case, the alginate molecules were physically cross-linked by
electrostatic bridging between anionic carboxyl groups on the alginate molecules and the
cationic divalent calcium ions. Previous studies have shown that hydrogel particles can
preserve probiotic cells over time when stored under wet conditions or when exposed to
simulated GIT fluids (Morin et al., 1992; Groboillot et al., 1993; Divya and Nampoothiri,
2015). However, there has been little research on the preservation of probiotics under dry
conditions, which may be important for future commercial application of lactococcal-
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based probiotics in a variety of food matrices. The aim of this study was therefore to
investigate the protection of encapsulated L. lactis cells under dry aerobic conditions.
2.3

Materials and methods

2.3.1

Bacteria propagation and general growth conditions
Lactococcus lactis subsp. cremoris LM0230 were routinely stored at -80 °C in

deMan, Rogosa, Sharpe (MRS) broth (Oxoid, Basingstoke, Hampshire, UK) enriched
with 50% glycerol (Sigma, St. Louis, MO, USA). The bacteria were grown in MRS broth
at 37 °C for 22 h, and maintained on MRS agar (Oxoid). Anaerobic conditions were
maintained using a double chamber anaerobic hood with airlock (82% N2, 10% CO2 and
7% H2; Coy Laboratory products, Grass Lake, MI, USA). Cells were harvested by
centrifugation at 4000 g for 15 min followed by separation from the supernatant.
2.3.2

Probiotic microencapsulation
L. lactis cells were encapsulated by means of ionotropic gelation using an

automated encapsulation instrument with a vibrating extrusion nozzle. 96 mL of 1%
(w/v) alginate solution (HG400, TIC Gums, Belcamp, MD, USA) was prepared and
autoclaved. The sterile alginate solution was mixed with 4 mL of ~109 CFU/mL probiotic
bacteria that had been concentrated in sterile 0.85% sodium chloride solution (Fisher,
Fair Lawn, NJ, USA). The polymeric matrix was agitated to uniformly distribute cells
throughout the mixture. The mixture was left to stand for 5 min to allow dissolved air to
leave the solution prior to bead preparation using an automated encapsulation device
(Büchi B-390 Encapsulator, Flawil, Switzerland) with a nozzle size of 120 µm, as per the
manufacturer’s standard operating conditions (frequency 800 Hz, electrode 800 V,
pressure 300 mbar). The beads were collected into 300 mL of 0.1 M calcium chloride
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solution (Sigma, St. Louis, MO, USA). After 1 or 24 hours under continuous agitation to
allow cross-linking, the beads were vacuum-filtered, rinsed with sterile deionized water
(200 mL), and then filtered again. The resulting samples were stored aerobically in sterile
Petri dishes at 24-26 °C for up to 4 weeks to model long-term storage conditions.
Unfilled alginate beads were prepared in parallel, with the exception of not adding
L. lactis to the alginate solution. 100 mL of 1% alginate solution was extruded into 300
mL of 0.1 M CaCl2 solution under continuous agitation. The working parameters (nozzle
diameter, frequency, charge and pressure), filtering steps and storage conditions used
were the same as those for the preparation of filled alginate beads.
2.3.3

Determination of calcium alginate bead size distribution
The particle size distribution was determined by static light scattering

(Mastersizer S, Malvern Instruments, Worcestershire, UK). Samples were diluted and resuspended in water (1 mL beads in 10 mL) to avoid multiple scattering effects and to
ensure they were homogeneous prior to analysis. Volume-based (D [4,3]) and surfacebased (D [3,2]) mean diameter measurements were obtained for all samples.
2.3.4

Optical microscopy
The overall appearance of filled and unfilled calcium alginate beads was

inspected and characterized by optical microscopy. A microscope (C1 Digital Eclipse,
Nikon, Tokyo, Japan) with 20, 40 and 60× objective lenses was used to capture images of
the beads. Alginate suspensions were vortexed to separate individual beads. All optical
images were taken using a digital camera and then characterized using the instrument
software (EZ CSI version 3.8, Nikon).
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2.3.5

Scanning electronic microscopy (SEM)
The microstructure of the beads was also characterized using a scanning electron

microscope (JCM-6000 NeoScope Benchtop SEM, Jeol, Tokyo, Japan). To prepare the
samples prior to analysis, calcium alginate beads were air-dried at room temperature for
at least 24 hours on Petri dishes. Subsequently, the beads were spattered with 10 nm gold
and mounted on an aluminum stud, which was loaded into the microscope. Images of the
calcium alginate beads were recorded in randomly selected fields.
2.3.6

Confocal scanning laser microscopy (CLSM)
To locate and visualize L. lactis cells within the alginate capsules it was necessary

to label the cells with a dye (acridine orange). Briefly, an aliquot of the sample containing
alginate beads was suspended in a solution of 0.1% acridine orange hemi (zinc chloride)
salt (Sigma, St. Louis, MO, USA) for 30 min to stain the microorganisms (i.e. DNA).
Excess fluorochrome was removed by washing (3×). The samples were drop-casted onto
glass slides and were observed using a confocal laser-scanning microscope (C1 Digital
Eclipse, Nikon, Tokyo, Japan) with an excitation and emission wavelength of 455 and
490 nm respectively.
2.3.7

Enumeration of viable cells
To determine viable counts of encapsulated bacteria, 0.1 g of alginate beads was

re-suspended in 9.9 mL of 10% sodium citrate dihydrate solution (pH 8.2; Fisher,
Fairlawn, NJ, USA) followed by vortexing for 10 minutes at room temperature. The
number of released cells was determined by plate count on solid agar, serial dilutions of
dissolved beads (102-107) were plated in duplicate and incubated at 37 °C anaerobically
for 40 h. Samples were taken once per week over a four-week period. The initial cell
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count (before bead formation) was determined by plating serial dilutions (105 -108) in
duplicate of the starting alginate-bacteria mixture before gelation on MRS agar. These
were incubated at 37° C under anaerobic conditions for 24 h followed by cell
enumeration.
Free cells (non-encapsulated bacteria) were also maintained under aerobic
conditions at 24-26°C to compare with encapsulated cells. Survival of free cells was
determined using a spread plate count on MRS agar. Dried cell pellets were re-suspended
in 50 mL sterile distilled water and vortexed. Serial dilutions (100-108) of the cell
suspension were sampled in triplicate and incubated at 37°C anaerobically for 40 h
followed by enumeration. Samples were taken every other day over a two-week period.
2.3.8

Statistical analysis
The mean of two or three individual determinations was used to calculate cell

counts and particle size. Cell counts and particle size distributions were analyzed using 2sample t-test (=0.05). Significant differences among individual means were determined
using Tukey’s HSD test.
2.4

Results
Mean particle diameters and particle size distributions of alginate beads prepared

with and without L. lactis cells using 1 or 24-hour gelation periods were compared with
each other (Table 2.1, Figure 2.1). After 1 hour incubation in the calcium bath, the
probiotic-loaded alginate beads had a relatively wide particle size range (diameter from 7
to 480 µm) with an average diameter of 161 ± 107 µm. After 24 hour incubation, the
particle size increased slightly but not significantly, with a range from 7 to 650 µm and
an average diameter of 188 ± 132 µm in diameter. These values were not significantly
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different from the unloaded alginate beads prepared in the absence of probiotics, which
had average particle diameters of 130± 94 and 155 ±116 µm for 1 and 24 hour gelation
respectively. Thus, the presence of the bacterial cells in the initial alginate solution did
not significantly increase average bead size.
Table 2.1:
Mean particle diameters of alginate beads prepared with and without
Lactococcus lactis cells for two gelation time periods. Averages were determined by
static light scattering. Values are shown as volume-based (D [4,3]) or surface-based (D
[3,2]) mean ± standard deviation.
Beads
No cells, 1 h gelation
No cells, 24 h gelation
Cells, 1 h gelation
Cells, 24 h gelation

D [4,3]

D [3,2]
µm

198 ± 94a
241 ± 94a
232 ± 89a
281 ± 119a

130 ± 94b
155 ±116b
161 ±107b
188 ±132b

Optical micrograph images of free cells, immobilized cells, and unfilled alginate
beads were captured for comparison (Figure 2.2). The free cells were coccoid shaped and
densely clustered. Similar cell morphology was observed for the probiotics trapped
within the filled alginate beads. Unfilled beads did not contain any visible
microorganisms. Fresh beads appeared spherical, but flattened into irregularly shaped
granules as they dried as seen in SEM analysis. Beads gelled for 1 and 24 hours did not
differ morphologically regardless of hydration status.
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Figure 2.1: Particle size distribution of alginate beads prepared with and without
Lactococcus lactis cells for two gelation time periods. Fresh samples were analyzed by
static light scattering. Samples include beads that lacked or contained L. lactis and gelled
for 1 or 24 hours.

21

Figure 2.2: Optical microscope images of (A) Lactococcus lactis LM0230 (40×),
(B) unfilled alginate microbead (40×), and filled alginate beads gelled for (C) 1 hour
(40×) and (D) 24 hours (40×). All scale bars represent 100 µm.
Scanning electron micrographs also showed the presence of coccoid cells that
were around 1 to 2 µm in length protruding from filled alginate beads (Figure 2.3). The
unfilled alginate beads lacked these protrusions, consistent with the lack of bacterial cells
incorporated in the preparation. Alginate beads gelled for 1 and 24 hours lost their
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spherical structure during desiccation and exhibited irregular shapes with pronounced
wrinkles and folds.

Figure 2.3: Scanning electron microscope images of (A) Lactococcus lactis
LM0230 (5000×), (B) unfilled alginate microbead (500×), and filled alginate beads
gelled for (C) 1 hour (400×) and (D) 24 hours (1100×). Samples were dried before
sputter-coating with gold. SEM was set at high-vacuum, 10 kV.
Confocal microscopy was also employed to detect the location of the bacteria
within the hydrogel beads, by using acridine orange, which intercalates into bacterial
DNA (Figure 2.4). The free cells interacting with the stain produced green fluorescence.
As expected, empty microbeads did not fluoresce brightly due to the absence of bacteria.
In contrast, bacteria encapsulated in alginate beads provided strong fluorescence
concomitant with the presence of cells.
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Figure 2.4: Confocal microscope images of (A) Lactococcus lactis LM0230, (B)
unfilled alginate microbead, and (C) filled alginate beads. Samples were stained with
acridine orange fluorescent dye to detect DNA. All scale bars represent 5 µm.
The total cell population decreased significantly over several weeks for all
samples (Figure 2.5, Table A.1). After 1 week, the average cell population showed a 1.5
log reduction from beads gelled for 24 hours and a 1.7 log reduction for those gelled for 1
hour. In contrast, a 5.4 log reduction occurred over the same time for free cells. After
about two weeks, a 3.1 and 4.1 log reduction was shown for 24 and 1 hour gelled beads
respectively. The decrease in cell viability over time was not significantly different
between beads gelled for 1 hour and 24 hours.
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Figure 2.5: Survival of free and encapsulated Lactococcus lactis LM0230 in
calcium alginate beads during dry room temperature storage. Counts are based on
samples spread-plated on MRS and incubated at 37°C anaerobically. Error bars represent
standard error of replicate samples.
2.5

Discussion
The encapsulation method used produced alginate beads that were able to protect

live L. lactis cells against loss of viability over several weeks. Previous studies have not
reported particle size distributions of L. lactis encapsulated solely within calcium alginate
beads. Nevertheless, they have been reported for other types of hydrogel particles. For
example, Groboillot et al. (1993) reported that L. lactis encapsulated within beads
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prepared using 2% chitosan using an emulsion-templating method yielded beads with
mean diameter of 0 µm (Groboillot et al., 1993). Whereas Hyndman et al. (1993)
encapsulated bacteria within beads prepared using 24% gelatin in a similar method that
had mean diameters around 124 µm (Hyndman et al., 1993). The dimensions of the
beads produced may be important for a number of reasons. First, it may influence the
effectiveness of the hydrogel beads to maintain the viability of the probiotics. Second, it
may influence the physical stability of the beads within food products, e.g., to
sedimentation, flocculation, and coalescence. Third, it may influence the
physicochemical properties of food products that the beads are incorporated into, such as
rheology and appearance. Finally, it may influence the sensory perception of a functional
food product, as large beads may lead to a grainy mouthfeel. Future studies in our
laboratory will therefore examine the influence of particle dimensions on the functional
performance of hydrogel beads loaded with L. lactis cells.
The optical and electron microscopy images confirmed that the probiotic bacteria
were trapped inside of the calcium alginate beads, and that the bacteria had dimensions of
about 1 to 2 µm in length. These results are consistent with previous microstructure
studies of encapsulated bacteria (Hansen et al., 2002; Fareez et al., 2015). Alginate alone
is able to encapsulate L. lactis by cross-linking via calcium ions although the beads
formed typically have a relatively low mechanical stability and are sensitive to chelating
compounds such as phosphate, citrate, EDTA and lactate, or anti-gelling cations such as
Na+ and Mg2+ (Willaert, 1996). Such factors may be found in bioprocessing environments
or within the gastrointestinal tract (Wyss et al., 2004). For this reason, it may be
necessary to improve the encapsulation process by blending the alginate with other
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polymers or by adding additional coats to the beads (Krasaekoopt et al., 2003). There are
a number of important criteria for any successful delivery system for L. lactis: the
probiotics should initially be located within the interior of the hydrogel beads; the beads
should provide an internal environment that protects the bacteria from degradation; the
beads should maintain their physical integrity throughout manufacture, transport, and
storage, and well as during passage through the GIT; the bacterial cells should be
released after arrival in the colon.
A medium viscosity sodium alginate was used for these experiments to prepare
the calcium alginate beads. We also investigated the use of a low viscosity sodium
alginate, although we observed poor performance, i.e. the beads were too fragile to
handle properly (data not shown). Beads stored in dry aerobic (room temperature)
conditions contained viable cells for over 4 weeks representing a significant improvement
over the non-encapsulated (free) cells. The total cell count fell below 106 CFU/g after 3
weeks indicating a considerable stability relative to the control conditions and typical of
handling lactococcal strains in the laboratory. Ultimately the diffusion of oxygen as well
as slow drying may have caused the eventual decrease in viable counts as expected. The
cell count model used assumes a uniform concentration of cells throughout the samples.
However, heterogeneous exposure to the atmosphere in combination to irregular bead
shape could cause variation of cell viability within beads, which will be explored in
future studies. Previous studies have stored microbeads as freeze-dried samples (Lee et
al., 2004; Chávarri et al., 2010; Kanmani et al., 2011), as hydrated samples at
refrigeration temperatures (Sheu and Marshall, 1993; Sultana et al., 2000), or as frozen
samples (Amine et al., 2014b), before incorporation into a food product or performing
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microbial count analysis. These storage methods maintained the spherical shape of the
original alginate beads, but have the disadvantage that greater energy needs were required
to prepare or store the samples.
Drying has been previously shown to have a deleterious effect on probiotic
viability (Efiuvwevwere et al., 1999). L. lactis was previously shown to undergo a 3-4 log
reduction after 3 days when dried at 20 and 30 °C (Efiuvwevwere et al., 1999). In
contrast, our encapsulated samples underwent a 3-4 log reduction after 2 weeks. It should
be noted that their study used L. lactis subsp. lactis, started with lower concentration of
cells and may have had a few variations in methodological parameters.
Increasing the gelation time from 1 hour to 24 hours did not add statistically
significant protection to immobilized cells, although the general trend was increased
viability. The maturation kinetics of calcium alginate beads (unfilled) was previously
characterized, and it was noted that the density of the beads decreased over time, then
levelled off after about 6 hours (Puguan et al., 2014). This suggests that syneresis
occurred, producing drier beads with increased gelation time. This in turn may influence
drying rate, and alter cell viability. The effect of gelation time on cell viability has not
been previously explored and remains a target parameter to optimize in future studies.
In summary, we demonstrated that encapsulation of L. lactis in calcium alginate
microbeads shielded the microbes from stresses encountered during drying conditions.
Dehydration of the samples caused the alginate beads to adopt irregular-shaped
structures, but the viability of the microbial cells was greatly increased compared to nonencapsulated cells. In the future, preserving spherical morphology of the beads may be
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achieved by incorporating other biopolymers into the coating material to potentially
increased strength and decrease porosity.
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3.1

Abstract

Probiotic microorganisms are incorporated into a wide variety of foods, supplements, and
pharmaceuticals to promote human health and wellness. However, maintaining bacterial
cell viability during storage and gastrointestinal transit remains a challenge.
Encapsulation of bifidobacteria within food-grade hydrogel particles potentially mitigates
their sensitivity to environmental stresses. In this study, phylogenetically related
Bifidobacterium longum subspecies and strains were encapsulated in core-shell microgels
consisting of an alginate core and a microgel shell. Encapsulating obligate anaerobes
Bifidobacterium longum subsp. infantis and Bifidobacterium longum subsp. longum
strains showed little difference in viability over time, suggesting minimal divergence in
stress response programs. This includes viability under aerobic storage conditions and
modeled gastrointestinal tract conditions. Coating alginate microgels with chitosan did
not improve viability compared to cells encapsulated in alginate microgels alone; this
suggests that modifying the surface charge alone does not enhance viability. Thus
hydrogel beads have great potential for improving the stability and efficacy of
bifidobacterial probiotics in various nutritional interventions.
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3.2

Introduction
Beneficial bacteria are often incorporated into functional foods and nutritional

interventions to be ingested orally as probiotics. This includes humans and livestock
animals that receive direct-fed microbials to enhance health outcomes and reduce
pathogen load (Braat et al., 2006; Puccio et al., 2007; Neal-McKinney et al., 2012;
Watson and Preedy, 2015). Bifidobacterium longum colonizes the human gastrointestinal
tract (GIT) and is one of the 48 recognized taxa that are encompassed within the genus
Bifidobacterium (Garrido et al., 2013; Sun et al., 2015). This obligate anaerobe is one of
the earliest colonizers of the infant GIT, and is present in lower concentrations in the
adult gut (Schell et al., 2002; Sela et al., 2008). The bifidobacterial taxa longum, infantis,
and suis were previously classified as discrete species, but more recently they were
reclassified as subspecies of Bifidobacterium longum (Sakata et al., 2002). Their
unification as a single species is based primarily on genomic and phenotypic similarities
shared between these groups.
B. longum is deployed in several probiotic applications using a variety of delivery
formats (Adhikari et al., 2000; Fortin et al., 2011; Amine et al., 2014a; Lewis et al.,
2015). A relatively large dose of probiotics is recommended to impart health benefits,
typically 106-107 CFU/g per day (Krasaekoopt et al., 2003; Roy, 2005). However, the
direct incorporation of free probiotic cells into food products and supplements results in a
significant decrease in cell viability throughout storage and gastrointestinal transit
(Sultana et al., 2000; de Vos et al., 2010). Therefore, prolonged storage and the process
of ingesting these probiotics may reduce their viability below recommended levels to
achieve health benefits. Microencapsulating probiotic cells within hydrogel matrices
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protects them against extrinsic environmental factors thereby enhancing bacterial survival
during processing, storage, and digestion (de Vos et al., 2010; Fareez et al., 2015; Yeung
et al., 2016a). Encapsulation may also dictate the controlled release of the probiotic at the
precise anatomical site of activity within the gastrointestinal tract, thereby enhancing the
efficacy of the probiotic through specific targeting after oral delivery (de Barros et al.,
2015; Zhang et al., 2015b).
Several biopolymer materials are available to encapsulate microbes in hydrogel
matrices, depending on the desired physicochemical properties of the delivery vehicle.
The most commonly used food-grade biopolymers are proteins (e.g., whey proteins and
caseins) and carbohydrates (e.g., starch and gums) (Bagchi et al., 2010; Gaonkar et al.,
2014; Etchepare et al., 2015). For many food applications, it is advantageous to
encapsulate probiotics within hydrogel beads that trap bacteria within small particles
containing cross-linked biopolymer molecules. These microgels must be engineered to
encapsulate high concentrations of probiotics and protect them from environmental
stresses, such as acidic pH, bile salts, and digestive enzymes (Zhang et al., 2015a).
Alginate has been widely used as a biopolymer suitable for food applications as it is
relatively inexpensive, easy to gel, biodegradable, and compatible with many food
systems (Gombotz and Wee, 2012; Lee and Mooney, 2012). Indeed, recently studies have
shown that lactococcal-based probiotics can be encapsulated within alginate microgels to
improve their stability (Yeung et al., 2016a).
There are appreciable differences between probiotic strain tolerance towards
environmental and gastrointestinal stresses. Consequently, it is possible to identify
particular strains that are more resistant to these stresses than others, which are therefore
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more suitable for commercial application (Godward, 2000; Krasaekoopt, 2004; Capela et
al., 2006). As an anaerobe, bifidobacteria are sensitive to oxygen exposure and to other
environmental stresses during the preparative phase prior to probiotic deployment.
Therefore, bifidobacterial probiotics may be encapsulated to restrict oxidative damage
during preparation and storage and to limit exposure to degradative processes within the
gastrointestinal tract.
The aim of this study was to design, fabricate, and characterize a food-grade
encapsulation system to protect B. longum cells during simulated storage and
gastrointestinal passage. Previously, we demonstrated that encapsulation of probiotics
within alginate microgels could improve their viability during storage (Yeung et al.,
2016a). In the current study, we encapsulated Bifidobacterium longum cells within
alginate beads to determine if their viability could be enhanced in storage and
gastrointestinal transit. Moreover, the impact of coating these alginate beads with a layer
of chitosan was investigated as well. Chitosan coated alginate beads have previously been
used to enhance the mucoadhesive properties of probiotic bacteria (Chen et al., 2013).
3.3

Materials and methods

3.3.1

Preparation of bacterial cultures
Four strains of both Bifidobacterium longum subsp. longum (B. longum) and

Bifidobacterium longum subsp. infantis (B. infantis) were studied (Table 3.1). Stock
solutions were maintained by storing bacteria at -80 °C in deMann, Regosa, Sharpe
media with 0.05% L-cysteine in 25% glycerol. Bacteria were propagated in MRS with Lcysteine (MRSC) at 37°C for 24 h, checked for purity, and maintained on MRSC agar
anaerobically. Anaerobic conditions were maintained in a double chamber anaerobic
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hood with an airlock (88% N2, 10% CO2 and 2% H2) from Coy Laboratory Products
(Grass Lake, Mississippi, USA).
Table 3.1:
Bifidobacterium longum strains selected for encapsulation. Four strains
are classified under subspecies infantis, and the other four strains are classified under
subspecies longum.
Subspecies
infantis

longum

Strain
designation
UMA 298
UMA 299
UMA 300
UMA 305
UMA 306
UMA 318
UMA 401
UMA 402

Isolated colonies were routinely propagated in MRSC broth (50 mL) for 40 hours
at 37° C. Cells were harvested by centrifugation at 4000 g for 10 min, washed twice with
0.85% NaCl (physiological saline) solution (25 mL), and suspended in 0.85% NaCl (2
mL). The resulting cell suspensions were used either directly for assessing survival of
free cells (i.e. no encapsulation) or subjected to encapsulation as described in section 2.3.
Free cell suspensions (2 mL) were stored in 0.85% NaCl solution (50 mL) at 2-5 °C for
up to five weeks to model long-term storage conditions.
3.3.2

General chemicals used in encapsulation and modeled digestion
For bacterial culture preparation, MRS broth was obtained from Becton

Dickinson and Company (Sparks, Maryland, USA). Agar, L-cysteine hydrochloric acid,
and sodium chloride (NaCl) were purchased from Sigma Aldrich (St. Louis, Missouri,
USA). Glycerol and sodium citrate dihydrate was purchased from Fisher Scientific (Fair
Lawn, New Jersey, USA).
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For encapsulation experiments, sodium alginate (TICA-algin® HG 400 powder)
was donated by TIC Gums (White Marsh, Maryland, USA). Calcium chloride
hexahydrate, chitosan (medium molecular weight) was obtained from Sigma Aldrich.
Glacial acetic acid was purchased from Fisher Scientific.
For simulated digestion, ammonium nitrate, bile extract porcine, lipase from
porcine pancreas type II, pepsin from porcine gastric mucosa, porcine gastric mucin type
II, potassium chloride, potassium citrate, potassium phosphate, sodium DL-lactate,
sodium hydroxide (NaOH), and uric acid sodium salt were also purchased from Sigma
Aldrich. Hydrochloric acid (HCl), phosphate buffer saline (PBS), and urea were
purchased from Fisher Scientific.
3.3.3

Microencapsulation of bifidobacterial cells
Bifidobacteria were encapsulated within alginate microgels using an injection-

gelation method (Whelehan and Marison, 2011; Seiffert, 2013). Briefly, 1% (w/v)
sodium alginate solution was prepared, autoclaved, and then cooled to ambient
temperature. The sterile alginate solution (198 mL) was mixed with 2 mL of ~109
CFU/mL probiotic organisms suspended in physiological saline. The polymeric solution
was agitated to uniformly distribute cells throughout the mixture. The alginate beads
were prepared aseptically using an encapsulator (Büchi B-390, Büchi Labortechnik AG,
Flawil, Switzerland) with a nozzle size of 120 µm, using the manufacturer’s standard
operating conditions (amplitude 3, frequency 800 Hz, electrode 800 V, pressure 250-300
mbar). Aliquots of probiotic/alginate solution were injected into 0.1 M calcium chloride
solution (350 mL). After 1-hour gelation under agitation, the resulting calcium alginate
beads were collected by filtration, rinsed with sterile deionized water (200 mL), and re-
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filtered. Microbeads (~30 mL) were stored in physiological saline solution (50 mL) at 4°
C for up to 4 weeks to model long-term storage conditions. This process was repeated for
all eight strains of bifidobacteria.
Unfilled alginate beads were prepared identically but without the addition of
bacterial strains to the alginate solution. 1% alginate solution (200 mL) was extruded into
of 0.1 M CaCl2 (350 mL) solution under continuous agitation. The working parameters
(nozzle diameter, frequency, charge and pressure), filtering steps and storage conditions
used were the same as those for the preparation of filled alginate beads.
An aqueous chitosan solution (0.4% w/v) was prepared as described previously by
Zhou et al. (1998). Briefly, chitosan (0.4 g) was dissolved in distilled water (90 mL) and
glacial acetic acid (0.8 mL). The pH was adjusted to 5.0-5.1 with NaOH, and the total
volume was adjusted to 100 mL. The solution was autoclaved and filtered to remove
undissolved solids. Subsequently, the alginate beads were submerged in the chitosan
solution to provide a secondary coating by electrostatic attraction of the cationic chitosan
molecules to the surfaces of the anionic alginate beads. The mixture was agitated for one
hour before filtering and rinsing beads with sterile distilled water. Chitosan-coated
alginate beads were then stored and analyzed.
3.3.4

Particle size distribution
The particle size distribution was determined by static light scattering

(Mastersizer S, Malvern Instruments, Worcestershire, UK). Each sample (1-2 mL) was
suspended in distilled water (10 mL) and vortexed to avoid multiple scattering effects and
to ensure homogeneity prior to analysis. Volume-weighted (D [4,3]) and surfaceweighted (D [3,2]) mean particle diameters were obtained for all samples.
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3.3.5

Optical microscopy
The overall appearance of alginate and chitosan-coated alginate beads was

characterized with an optical microscope (C1 Digital Eclipse, Nikon, Tokyo, Japan).
Microgel suspensions (1-2 mL) were immersed in physiological saline (10 mL) and
vortexed to separate individual beads. Optical images were obtained using a digital
camera and further analyzed using the instrument software (EZ CSI version 3.8, Nikon).
3.3.6

Scanning electronic microscopy (SEM)
The bead microstructure was characterized using a bench-top scanning electron

microscope (JCM-6000 NeoScope, JEOL, Tokyo, Japan). To prepare the samples prior to
analysis, alginate and chitosan-coated alginate beads were freeze-dried and sputter-coated
with gold (10 nm) before loading onto the microscope. Images of the microgels were
documented in representative fields.
3.3.7

Electrical properties
The surface potential (ζ-potential) of alginate and chitosan-coated alginate

microgels was evaluated by electrophoretic light scattering (Zetasizer Nano ZS, Malvern
Instruments, Worcestershire, UK). For each sample, refrigerated microgels (1-2 mL)
were suspended in distilled water (10 mL) and vortexed to separate the beads. Samples
were then loaded into the measurement cells and analyzed.
3.3.8

Modeled long-term storage conditions of encapsulated bifidobacteria
Total cell counts of free and encapsulated bifidobacteria were determined by a

modified drop plate method as previously described (Herigstad et al., 2001). Briefly, 10
drops (10 µL) of a dilution within a series (100 – 107) were deposited on MRSC agar
plates and counted after incubation under anaerobic conditions at 37°C.
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To determine viable counts of the encapsulated bacteria, beads (1 mL) were resuspended in 10% sodium citrate dihydrate solution (9 mL) followed by vortexing. The
number of released cells was determined by plate count using MRSC agar, dilutions of
dissolved beads (10-1-10-7) were plated in duplicate and incubated at 37°C anaerobically
for 40 h. For lower viability samples later, beads (2 mL) were re-suspended in 10%
sodium citrate dihydrate solution (2 mL) instead, and dilutions (100-10-3) were plated as
before. Samples were taken over a four-week period on days 0 (initial), 1, 3, 5, 7, 10, 14,
21, and 28. Days 17 and 24 were also plated for free cell samples.
3.3.9

In vitro simulated digestion of free and encapsulated bifidobacteria in chitosan-

coated alginate microbeads
Free and encapsulated bifidobacteria were exposed to simulated digestion phases
(Figure 3.1). Fluids used in in vitro modeling of digestion were prepared based on the
method described by Li et al. (2011). One liter of modeled saliva stock solution was
prepared with ammonium nitrate (0.328 g), potassium chloride (0.202 g), potassium
citrate (0.308 g), potassium phosphate (0.636 g), sodium chloride (1.594 g), sodium DLlactate (0.146 g), urea (0.198 g), and uric acid sodium salt (0.021 g) in distilled water.
The stock solution was then filter-sterilized. The day before digestion experiments were
carried out, the salivary phase was prepared by adding porcine gastric mucin type II (2.4
g) to saliva stock solution (80 mL). The solution was stirred overnight at room
temperature to completely dissolve the powder.
One liter of simulated gastric stock solution was prepared by adding sodium
chloride (2 g) and hydrochloric acid (7 mL) to distilled water and filter sterilizing. The
simulated intestinal stock solution (500 ml) was prepared by adding calcium chloride
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hexahydrate (27.38 g) and sodium chloride (109.685g) to distilled water and autoclaved.
Pepsin extracted from porcine gastric mucosa (0.32 g) was then added to gastric stock
solution (100 mL).
The day before digestion experiments were carried out, porcine bile extract (0.75
g) was added to PBS solution (14 mL) for the modeled intestinal phase. The solution was
stirred overnight at room temperature to completely dissolve the powder. Lipase from
porcine pancreas type II (0.24 g) was dissolved in PBS solution (10 mL); the solution (5
mL) was then added with bile salt solution (7 mL) and intestinal stock solution (33 mL).
Free and encapsulated bifidobacteria cells were separately added to simulated
saliva fluids (22 mL, pH adjusted to 6.7-6.8), simulated gastric fluids (45 mL, pH
adjusted to 2.5-2.6) or simulated intestinal fluids (45 mL, pH adjusted to 7.0-7.2).
Dilutions (100-105) were plated on MRSC agar for initial, 5, 10, 15, 20, or 30 minutes
exposure and incubated anaerobically for at least 48 hours.
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Figure 3.1: Experimental design for simulated digestion of free and encapsulated
Bifidobacterium longum subsp. infantis UMA 299. Samples were exposed to salivary
(containing mucin, pH 6.7-6.8), gastric (containing hydrochloric acid and pepsin, pH 2.52.6), and intestinal (containing bile salts and lipase, pH 7.0-7.2) phases separately. One
milliliter samples were obtained at times 0 (before exposure), 5, 10, 15, and 30 minutes
exposure.

3.3.10 Statistical analysis
The mean of 2 or 3 individual determinations was used to calculate particle size,
ζ-potential, and cell counts. Analysis of variance (ANOVA) followed by Tukey honest
significant difference test was use to analyze all data and compare individual means. This
was performed using statistical software (GraphPad Prism 6, GraphPad Software, La
Jolla, California, USA).
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3.4

Results
Light scattering was used to determine the mean particle diameter of the different

microgel samples (Table 3.2). The mean particle sizes of alginate beads containing
similar strains were similar, ranging from 135 to 185 µm (D [3,2]) for encapsulated B.
infantis strains and 149 to 216 µm (D [3,2]) for encapsulated B. longum strains. The
chitosan-coated alginate beads were significantly larger compared than the alginate
beads, ranging from 191 to 292 µm (D [3,2]). This increase in particle size may have
been because of the additional coating formed by the alginate molecules, or because of
some aggregation of the microgels. Microgel aggregation may have occurred due to
bridging flocculation, which is the ability of the chitosan cation to adsorb to the surfaces
of two or more anionic alginate beads. Additional information about the structural
configuration of the microgels was therefore obtained through microscopy.
Table 3.2:
Mean particle diameters of alginate and chitosan-coated alginate
beads containing strains of Bifidobacterium longum. Averages were determined by
static light scattering. Values are shown as volume-based (D [4,3]) and surface-based (D
[3,2]) mean ± standard deviation. Values followed by the same letters in the same column
are not significantly different (p > 0.05) from each other.

Chit.-alg.

Alginate

Beads
Subsp.
infantis

Subsp.
longum
Subsp.
infantis
Subsp.
longum

UMA 298
UMA 299
UMA 300
UMA 305
UMA 306
UMA 318
UMA 401
UMA 402
UMA 299
UMA 300
UMA 401
UMA 402

D [4,3]

D [3,2]
µm

233±4ab
230±3ab
251±6a
211±4b
247±13ac
228±11ab
277±4cd
287±13de
327±2fg
344±14f
310±20eg
315±26efg

167±6abc
162±3b
185±12cd
135±2e
164±4ab
149±13abe
216±3f
195±3dfg
292±3h
237±3i
213±4f
191±11g
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The structures of samples containing free cells or bacterial-loaded microgels were
determined using optical microscopy immediately after encapsulation (Figure 3.2). Free
cells appeared rod-shaped as expected for bifidobacteria (Figures 3.2A and 3.2D). The
unfilled alginate and chitosan-coated alginate microgels were similar in morphology,
although the individual coated alginate beads did appear larger than the uncoated ones,
which is consistent with the particle size analysis (Figures 3.2B and 3.2E). Encapsulated
bifidobacteria were clearly visualized within the microgels for both alginate and chitosancoated alginate microgels (Figures 3.2C and 3.2F). The bifidobacterial-loaded alginate
and chitosan-coated alginate beads had a similar external appearance as the equivalent
unloaded beads. The microgels were generally spherical with diameters around 100 to
300 µm for all samples.
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Figure 3.2: Optical microscope images of (A) Bifidobacterium longum subsp.
infantis UMA 300 (20×), (B) unfilled alginate bead (20×), (C) filled alginate bead
with B. longum subsp. longum UMA 306 (20×), (D) B. longum subsp. longum UMA
318 (20×), (E) unfilled chitosan-coated alginate bead (20×), and (F) filled chitosancoated alginate bead with B. longum subsp. infantis UMA 299 (20×). All scale bars
represent 100 µm.

Scanning electron microscopy (SEM) was used to inspect the structure of the
alginate and chitosan-coated alginate beads (Figure 3.3). Freeze-dried microgels were
uniform in size and shape. However, the surfaces of the microgels observed by SEM
appeared wrinkled, whereas they presented as smooth when observed by optical
microscopy. This is likely due to sublimation of water originally trapped within the
hydrogel matrix, as has been described previously (Yeung et al., 2016a). The chitosancoated alginate beads appeared to be more irregular in shape compared to alginate beads.
Qualitatively, the alginate beads had smoother wrinkles and microstructures, whereas the
chitosan-coated beads exhibited sharp jagged edges. This observation suggests that the
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chitosan layer has been successfully deposited onto the external surfaces of the alginate
microgels.

Figure 3.3: Scanning electron microscope images of (A) Bifidobacterium longum
subsp. infantis UMA299, (B) unfilled alginate bead, (C) unfilled chitosan-coated
alginate bead, (D) B. longum subsp. longum UMA 306, (E) alginate bead containing
B. longum subsp. longum UMA 401, and (F) chitosan-coated alginate bead
containing B. longum subsp. infantis UMA 300. Samples were dried before sputtercoating with gold. SEM was set at high-vacuum, 10 kV.

Electrophoretic light scattering was used to evaluate the electrical characteristics
of the microgels (Table 3.3). The ζ-potentials of all the alginate beads were negative,
ranging from -4.2 to -9.4 mV for B. infantis and -2.6 to -4.4 mV for B. longum as
predicted with this coating. In contrast, all chitosan-coated alginate bead samples had
positive surface potentials ranging from +9.9 to +14.9 mV for B. infantis and +0.8 to +9.0
mV for B. longum. These results indicate that the cationic chitosan molecules formed a
secondary shell around the anionic calcium alginate beads.
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Table 3.3:
Zeta potential of alginate and chitosan-coated alginate beads
containing strains of Bifidobacterium longum. Values are shown as mean ± standard
deviation. Values followed by the same letters are not significantly different (p > 0.05)
from each other.

Chit.-alg.

Alginate

Beads
Subsp.
infantis

Subsp.
longum
Subsp.
infantis
Subsp.
longum

UMA 298
UMA 299
UMA 300
UMA 305
UMA 306
UMA 318
UMA 401
UMA 402
UMA 299
UMA 300
UMA 401
UMA 402

mV
-5.23±2.06ab
-9.42±2.54a
-8.73±4.88ª
-4.15±1.17ab
-3.14±2.24ab
-2.60±0.04ab
-4.38±0.64ab
-4.28±1.12ab
9.92±3.92c
14.87±4.26c
0.79±2.53bd
9.03±4.90cd

The viability of four B. longum and four B. infantis strains that were not
encapsulated was determined during five weeks of storage (Figure 3.4, Table A.2). As
expected, there was a decrease in the viability of the bifidobacteria evaluated, but the rate
of the decrease was strain dependent. A sharp decrease in viability was observed for B.
infantis UMA318 and B. longum UMA401, diminishing by 9-10 log CFU over the course
of a week under aerobic conditions. B. infantis UMA 300 and B. infantis UMA 305
remained viable for slightly longer, with a 10-log reduction observed within 10 days.
Whereas, B. infantis UMA 298 and B. infantis 306 exhibited a 9-10 log decrease over 2
weeks of storage. Interestingly, B. infantis UMA 299 and B. longum UMA 402 survived
the longest, as viable cell counts diminished by 7-8 logs over 3 weeks before decreasing
to undetectable levels.

46

Figure 3.4: Survival of free Bifidobacterium longum cells in wet refrigerated
storage over time. Counts based on samples drop-plated on MRSC agar incubated at
37°C anaerobically. Error bars indicate the standard error of replicate counts.

Viability following encapsulation was determined for all eight bifidobacterial
strains (Figure 3.5, Table A.3). There were distinct differences between the effects of
encapsulation depending on strain type. The cell viability of B. infantis UMA 298, B.
infantis UMA 305, and B. longum UMA 318 stains rapidly decreased and were
undetectable after 3 days. Unexpectedly, B. infantis UMA 298 and B. infantis UMA 305
in alginate were inactivated faster than the corresponding free cells, being undetectable
after 24 and 10 days respectively. Viability of the encapsulated B. longum UMA 318 was
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identical to that of free cells. B. infantis UMA 300, B. longum UMA 306, B. longum 401,
and B. longum 402 maintained viable populations that decreased by 3-4 log CFU after 10
days of storage before rapidly decreasing to zero. Encapsulated B. infantis UMA 300
survived three days longer than corresponding free cells; encapsulated B. longum UMA
401 lasted a week longer than free cells. Encapsulated B. longum UMA 306 survived
similarly to free cells, and encapsulated B. longum UMA 402 survived over a week
shorter than corresponding free cells. Interestingly, B. infantis UMA 299 viability was
enhanced as it experienced a 5 log CFU reduction in 3 weeks compared to an 8 log CFU
reduction during this time for the non-encapsulated cells. Thus, encapsulating with
alginate extended cell viability of B. infantis UMA 299 and 300 by a few days, and
extended viability of B. longum UMA 401 cells by a week. Encapsulating other B.
infantis and B. longum strains did not appear to extend viability over the storage
conditions used.

48

Figure 3.5: Survival of Bifidobacterium longum cells in calcium alginate
microbeads in wet refrigerated storage over time. Counts based on samples dropplated on MRSC agar and incubated at 37°C anaerobically. Error bars indicate the
standard error of replicate counts.

Two strains each of B. infantis (UMA 299 and 300) and B. longum (UMA 401
and 402) were encapsulated in a secondary coating of chitosan applied to the alginate
bead core and submitted to testing over time (Figure 3.6, Table A.4). B. longum UMA
401 and 402 both decreased 3-4 log within three days, and fell to undetectable levels by
two weeks. Viability of B. infantis UMA 299 and B. infantis UMA 300 decreased only 2
logs in five days, before falling to undetectable levels after two weeks. Encapsulating
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bifidobacterial cells in chitosan-coated alginate beads did not appear to extend viability
compared with uncoated alginate microbeads.

Figure 3.6: Survival of Bifidobacterium longum cells in chitosan-coated alginate
microbeads in wet refrigerated storage over time. Counts based on samples dropplated on MRSC agar and incubated at 37°C anaerobically. Error bars indicate the
standard error of replicate counts.

Free and bifidobacterial cells encapsulated in chitosan-coated alginate beads were
subjected to simulated digestion in a GIT model as previously described (Li et al., 2011).
Free B. infantis UMA 299 and cells encapsulated chitosan-coated alginate were immersed
separately in simulated salivary, gastric, and intestinal phases and assessed over time for
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cell viability (Table 3.4). The bacteria appeared to be relatively stable within simulated
saliva fluids, as less than a one log CFU reduction was experienced in 30 minutes of
exposure regardless of encapsulation. The model salivary juice did not greatly inhibit cell
viability in general, as less than one log CFU reduction was experienced in 30 minutes of
exposure regardless of encapsulation. However, microencapsulation provided enhanced
protection for UMA299 by shielding the strain from the low pH of the gastric phase.
Encapsulated cells decreased by 1.4 logs CFU, whereas untreated cells decreased by 2.7
logs following exposure to pH 2.5 conditions (5 minutes). This indicates a significant,
albeit fleeting protection afforded to the encapsulated cells as viability was abrogated
after 10 minutes of exposure to the gastric phase. Similarly, UMA299 cell viability was
not detectible after 5 minutes of exposure to the intestinal phase. B. longum UMA 402
encapsulated in chitosan-coated alginate was also subjected to simulated digestion. As
with B. infantis, cell viability remained stable in the modeled salivary phase, but
underwent a 6-log reduction after only a few minutes exposure to gastric phase (pH 2.5).
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Table 3.4:
Survival of free and encapsulated Bifidobacterium longum subsp.
infantis UMA 299 in three separate simulated digestion phases. Counts based on
samples drop-plated on MRSC agar and incubated at 37°C anaerobically. Values are
shown as mean ± standard error of replicate counts. Means within each column followed
by the same lowercase letters are not significantly different (p > 0.05) from each other.
Means within each row followed by the same uppercase letters are not significantly
different (p > 0.05) from each other.

pH
Time
(minutes)
0
5
10
15
30

3.5

Saliva
6.74

Free
Gastric
2.53

Intestinal
7.04

Encapsulated
Saliva
Gastric Intestinal
6.78
2.57
7.12

log CFU
9.63
±0.07aA
9.17
±0.06a
9.28
±0.09a
9.14
±0.06a
9.01
±0.06a

9.63
±0.07aA
6.99
±0.03b

9.63
±0.07aA

ND

ND

ND

ND

ND

ND

ND

8.40
±0.84abB
8.10
±0.05a
7.89
±0.07a
6.42
±1.07b
8.14
±0.040a

8.40
±0.84aB
6.90
±0.04a

8.40
±0.84aB

ND

ND

ND

ND

ND

ND

ND

Discussion
Initially, chitosan-coating of alginate beads was postulated to enhance the

viability of encapsulated probiotics by reducing their exposure to environmental stresses
during storage and within the gastrointestinal tract. Accordingly, the influence of
encapsulation on a panel of B. longum strains to assess differential viability was
systematically studied. The calcium alginate beads formed using an injection-gelation
method were roughly spherical in shape, negatively charged, and had dimensions around
130 to 220 µm. Coating the alginate beads with chitosan caused a small increase in their
size and changed their charge from negative to positive. Optical microscopy confirmed
that the bifidobacteria were immobilized within the hydrogel beads, which is consistent
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with previous encapsulation studies (Hansen et al., 2002; Fareez et al., 2015; Yeung et
al., 2016a).
Interestingly, encapsulation of bifidobacteria in chitosan-coated alginate beads led
to an appreciable improvement in their storage or gastrointestinal stability. One possible
explanation for this observation is that the alginate hydrogel used had relatively large
pores, and so small molecules, such as oxygen, acids, bile salts, or digestive enzymes,
could easily diffuse into the microgels and inactivate the encapsulated bacteria
(McClements, 2015). These results suggest that a simple secondary layer of chitosan
alone will not fully protect encapsulated bifidobacteria, and that further optimization is
required to engineer more effective delivery systems. Previous studies have shown that
alginate has a prebiotic effect on bifidobacteria, which might account for its ability to
enhanced viability, potentially through a non-encapsulation mechanism (Wang et al.,
2006; Ramnani et al., 2012). In future studies, it may be useful to examine the influence
of different biopolymer materials and methods on the ability of microgels to enhance
probiotic viability. As an example, the hydrogel pore size may be decreased to limit
molecular diffusion, with the addition of anti-oxidants to limit oxidation reactions and
prebiotics to stimulate probiotic growth in the colon. Since bifidobacteria ferment
oligosaccharides within the gut, a synbiotic approach that integrates prebiotic substrates
including plant or milk oligosaccharides may advance bifidobacterial-based delivery
(Sela, 2011). Alternatively, judicious selection of strain selection that are resistant to
acids, bile salts, or digestive enzymes may enhance the delivery scheme. However,
previous studies indicate that most bifidobacteria strains typically exhibit a significant
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decrease in survival around pH 4 which would necessitate shielding from gastric
conditions (Sun and Griffiths, 2000).
Bifidobacteria have been exposed to simulated digestive fluids in previously
conducted studies (O'Riordan et al., 2001; Hansen et al., 2002; Kamalian et al., 2014).
Although specific strains tested and experimental schemes vary between studies. Hansen
et al. (2002) encapsulated several bifidobacterial strains in microgels formed by an
emulsion-templating method, and then exposed them to simulated gastric and small
intestinal fluids. In this study, B. infantis and B. longum strains showed a 4-6 log
CFU/mL decrease between exposure to gastric fluids set at pH 6.0 and pH 2.0 for two
hours, and 3-5 log CFU/mL reduction between exposure to intestinal fluid containing 0%
and 1% bile for 24 hours. In a separate experiment, encapsulated B. longum experienced
a 5-log CFU/mL reduction after 30 minutes exposure to gastric juice (pH 2.0). In the
study herein, B. infantis UMA 299 encapsulated in chitosan-coated alginate underwent an
8-log reduction in a 10-minute exposure to gastric fluid (pH 2.6), and an 8-log reduction
in 5 minutes exposure to intestinal fluid. This study included 0.75% bile extract, pepsin,
and lipases were included in the gastric and intestinal fluids, for the purpose of simulating
the harsh conditions of the human GIT. In an additional study, an emulsion encapsulation
method was performed on Bifidobacterium pseudocatenulatum G4 in chitosan-coated
alginate and exposed to gastric conditions (pH 1.5) for two hours followed by intestinal
phase for five hours (Kamalian et al., 2014). The encapsulated B. pseudocatenulatum
experienced a 4-log reduction when encapsulated in alginate and a 2-log reduction in
chitosan-coated alginate, relative to the 5-log reduction in the control. However, this was
accomplished in the absence of digestive enzymes or bile salts in simulated gastric and
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intestinal fluids that would present additional hurdles to the bifidobacterial cells.
O'Riordan et al. (2001) studied spray-dried Bifidobacterium spp. PL1 in starch and
subjected the resultant granules to simulated digestion. After 3 hours of exposure to
buffer with pH 2.8, they were unable to detect viable cells as well as other sampling
points in between 0 and 3 hours. This is consistent with the results presented in this study.
In summary, bifidobacterial viability following encapsulation varied between
subspecies as well as strains. This suggests that there is a range of genotypic and
phenotypic factors contributing to stress responses that promote enhanced viability.
Further functional genomic analysis of encapsulated probiotic organisms can aid in
matching strains with the particular encapsulation process to optimize cell integrity
during storage. Moreover, similar approaches may be used in selecting ideal delivery
vehicles to shield bifidobacteria during GIT transit to arrive intact and metabolically
poised to exert beneficial activities in the distal colon.
3.6
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CHAPTER 4
CONCLUSION
The studies presented herein showed that encapsulating Lactococcus lactis
LM0230 improved viability during room-temperature (24-26°C) storage, while
encapsulating Bifidobacterium longum strains improved viability of some strains during
refrigerated (4°C) storage. This suggests that variations in oxygen tolerance as well as
other stress-inducing factors are species and strain-dependent. Hence, future studies
should optimize encapsulation formulation based on the genetic properties of the
probiotic strain, continue observing the effects of encapsulating other novel probiotic
strains (see Appendix B), and expand knowledge of prebiotic-probiotic interactions.
Incorporating antioxidants and buffering agents with encapsulated probiotics may
improve survival of bacterial strains sensitive to oxygen and high acidity. In vitro
encapsulation experiments of newly discovered or potential probiotics can characterize
their survival traits and evaluate their safety for use in foods, supplements, or medical
applications. Lastly, co-encapsulating beneficial microorganisms with indigestible or
bioactive food components may yield additive or synergistic health benefits for the
consumer. These areas of research will improve overall survival of probiotic delivery to
the colon, and therefore improve host health.
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APPENDIX A
SUPPLEMENTAL DATA

Corresponding data for graphs shown in Chapters 2 and 3 are included here.

Table A.1: Survival of Lactococcus lactis subjected to drying at room
temperature (22-25°C). Values are based on duplicate (with †) and triplicate counts of
samples spread-plated on MRS and incubated at 37°C anaerobically and are shown as
mean ± standard error of the mean. Corresponding letters indicate values are not
significantly different (p > 0.05).
Time
0d
1d
3d
5d
7d
9d
11 d
2 wk
3 wk
4 wk
5 wk

Free Cells
10.94 ± 0.03a
10.83 ± 0.02a
8.86 ± 0.25cd
8.44 ± 0.12†cde
5.57 ± 0.02†gh
4.80 ± 0.13hi
4.24 ± 0.23†hi
4.68 ± 0.09hi
-

1 h gelation
log CFU
10.69 ± 0.03ab
8.97 ± 0.01bcd
6.60 ± 0.05efg
5.37 ± 0.14gh
-

24 h gelation
10.77 ± 0.03a
9.28 ± 0.05†abc
7.38 ± 0.60def
6.35 ± 0.72fg
5.71 ± 0.68gh
3.11 ± 0.08†i
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Table A.2:
Viability of free Bifidobacterium longum cells during refrigerated storage. Values based on samples drop-plated on
MRSC agar and incubated at 37°C anaerobically and are shown as mean ± standard error of mean. Means within each column
followed by the same lowercase letters are not significantly different (p > 0.05) from each other. Means within each row followed by
the same uppercase letters are not significantly different (p > 0.05) from each other.
Time
(days)
0
1
3

58
5
7
10
14
21

UMA 298
8.967
±0.044aA
7.770
±0.057abA
6.683
±0.745bcA
7.493
±0.080bAB
7.574
±0.072bA
5.754
±0.061cA
6.722
±0.060bcA
3.666
±0.624dA

24

ND

28
35

ND
ND

B. longum subsp. infantis
UMA 299
UMA 300
9.908
±0.043aAB
9.980
±0.017aB
9.667
±0.053abB
8.666
±0.459abC
8.579
±0.072bA
6.549
±0.071cA
6.045
±0.027cA
5.563
±0.085cB
3.093
±0.517dB
ND
ND

10.05
±0.018aBC
9.509
±0.072aB
8.588
±0.454aB
6.672
±0.357bB
7.510
±0.056bA
ND
ND
ND

UMA 305
UMA 306
log CFU
10.13
9.766
±0.084aBD
±0.060aACDE
10.025
9.592
±0.033aB
±0.050abB
7.303
8.648
±0.813bA
±0.072abcBC
5.572
8.539
±0.073cD
±0.074bcAC
3.895
7.719
±1.298dB
±0.058cA
6.057
ND
±0.077dA
6.511
ND
±0.120dA
4.628
ND
±0.523eAB

B. longum subsp. longum
UMA 318
UMA 401
9.536
±0.056aACDF
9.451
±0.060aB
7.623
±0.027bAC
ND

10.28
±0.047aBEF
3.388
±1.130bC
1.445
±0.736cD
4.126
±0.101bF

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND
ND

ND
ND

ND
ND

ND
ND

ND
ND

UMA 402
7.739
±0.175aG
9.365
±0.107bB
7.566
±0.071aAC
6.036
±0.685cBD
5.875
±0.113cD
8.516
±0.065abC
5.682
±0.057cA
7.270
±0.022aD
5.833
±0.018cC
ND
ND

Table A.3: Viability of Bifidobacterium longum cells encapsulated in calcium alginate during refrigerated storage. Values
based on samples drop-plated on MRSC agar and incubated at 37°C anaerobically and are shown as mean ± standard error of mean.
Means within each column followed by the same lowercase letters are not significantly different (p > 0.05) from each other. Means
within each row followed by the same uppercase letters are not significantly different (p > 0.05) from each other.
Time
(days)
0
1

UMA 298

59

8.959
±0.049aA
7.058
±0.085bA

3

ND

5

ND

7

ND

10

ND

14

ND

21

ND

24

ND

28

ND

35

ND

B. longum subsp. infantis
UMA 299
UMA 300
10.27
±0.054aB
9.694
±0.033aB
9.603
±0.020aB
8.121
±0.052bB
6.497
±0.030cB
6.298
±0.705cB
5.561
±0.031cB
N/A
3.415
±0.392dB
ND

9.508
±0.029aAB
8.018
±0.059bCD
7.233
±0.075bCD
6.196
±0.075cB
6.159
±0.041cB
1.571
±0.642dC

UMA 305
UMA 306
log CFU
9.793
10.07
±0.100aAB
±0.052aBC
8.791
9.088
±0.051bCE
±0.087bBEF
8.536
6.457
±0.030bE
±0.063cdC
4.883
7.453
±0.103cC
±0.839bB
8.785
±0.037bC
3.641
6.802
±0.413dC
±0.070cdB

B. longum subsp. longum
UMA 318
UMA 401
9.312
±0.026aACD
7.406
±0.047bAD
ND
ND
ND
ND

10.01
±0.069aBD
7.258
±1.214bCF
7.364
±0.056cDF
3.559
±0.782dD
N/A
5.020
±0.578eD
3.984
±0.444dD

UMA 402
9.545
±0.027aAB
8.394
±0.059bCF
7.202
±0.804cdCF
7.831
±0.021cB
6.355
±0.089dB
6.790
±0.025dB

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

Table A.4: Viability of Bifidobacterium longum cells encapsulated in chitosancoated alginate during refrigerated storage. Values based on samples drop-plated on
MRSC agar and incubated at 37°C anaerobically and are shown as mean ± standard error
of mean. Means within each column followed by the same lowercase letters are not
significantly different (p > 0.05) from each other. Means within each row followed by the
same uppercase letters are not significantly different (p > 0.05) from each other.
Time
(days)
0
1
3
5
7
10
14
21
24
28
35

B. longum subsp. infantis
B. longum subsp. longum
UMA 299
UMA 300
UMA 401
UMA 402
log CFU
10.31
10.19
10.11
9.637
±0.037aA
±0.052aA
±0.042aA
±0.023aA
9.764
9.660
6.424
±0.035aA
±0.028aA
±1.075bC
9.435
8.960
7.717
6.638
±0.032abA
±0.061abA
±0.024bB
±0.046bB
9.122
8.469
7.665
2.191
±0.080abA
±0.046bAB
±0.028bB
±0.894cC
8.356
6.544
2.356
±0.128bA
±0.063cB
±0.788cC
2.753
3.194
±0.603cA
±0.698cA
3.304
2.357
4.212
ND
±0.558cAB
±0.643dA
±0.076dB
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
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APPENDIX B
EXTENDING VIABILITY OF LACTOBACILLUS PLANTARUM AND
LACTOBACILLUS JOHNSONII BY MICROENCAPSULATION IN ALGINATE
MICROGELS

Introduction
Lactobacillus plantarum is a facultative Gram-positive rod-shaped bacterial
species commonly found on the surfaces of vegetation and is widely used for plant-based
fermentations (Boekhorst et al., 2004; Ferreira dos Santos et al., 2016). L. plantarum is
known to be relatively tolerant to acid and bile salts and can also secrete antimicrobial
compounds and adhere to the gut epithelial surface, discouraging growth and colonization
by pathogenic microorganisms (Cebeci and Gürakan, 2003; Ingham et al., 2008).
Lactobacillus johnsonii is a more fastidious related bacterial species that also resides in
the human gastrointestinal tract and has documented benefits to human health similar to
Lactobacillus plantarum, such as adhesion to gut epithelial cells to compete with
pathogens and immunomodulation (Boekhorst et al., 2004; Pridmore et al., 2004; Garrido
et al., 2005; Hertzberger et al., 2013).
Depending on the specific strain of Lactobacilli, the survival rate during
gastrointestinal transit is twenty to forty percent due to the challenges of gastric acidity
and bile salts present in the intestine (Bezkorovainy, 2001). Microencapsulating L.
plantarum and L. johnsonii in food-grade alginate shows promise to increase survival of
bacteria through the harsh conditions of the gastrointestinal tract. Although several studies
have previously observed the effects of encapsulating L. plantarum (Ding and Shah,
2007; Gbassi et al., 2009; Brinques and Ayub, 2011), to the authors’ knowledge, L.
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johnsonii has never been encapsulated. In this study, we compare the survival of free and
encapsulated L. plantarum and L. johnsonii cells during refrigerated storage as well as
during exposure to simulated digestion phases.

Materials and methods
General chemicals used in encapsulation and modeled digestion
For bacterial culture preparation, Lactobacilli MRS broth was obtained from
Becton Dickinson and Company (Sparks, Maryland, USA). Agar and L-cysteine
hydrochloric acid were purchased from Sigma Aldrich (St. Louis, Missouri, USA).
Glycerol, sodium chloride (NaCl), and sodium citrate dihydrate was purchased from
Fisher Scientific (Fair Lawn, New Jersey, USA).

For encapsulation experiments,

sodium alginate (TICA-algin HG 400 powder) was donated by TIC Gums (White Marsh,
Maryland, USA). Calcium chloride hexahydrate was obtained from Sigma Aldrich.
Glacial acetic acid was purchased from Fisher Scientific. For simulated digestion,
ammonium nitrate, bile extract porcine, lipase from porcine pancreas type II, pepsin from
porcine gastric mucosa, porcine gastric mucin type II, potassium chloride, potassium
citrate, potassium phosphate, sodium DL-lactate, sodium hydroxide (NaOH), and uric
acid sodium salt were also purchased from Sigma Aldrich. Hydrochloric acid (HCl),
phosphate buffer saline (PBS), and urea were purchased from Fisher Scientific.
Bacterial culture conditions
Lactobacillus johnsonii ATCC 33200 and Lactobacillus plantarum ATCC BAA793 cultures were obtained from the American Type Culture Collection and propagated
in deMan, Rogosa, Sharpe broth supplemented with 0.05% L-cysteine (MRSC). Stock
cultures were stored in MRSC with 25% glycerol at -80°C.
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Isolated colonies of L. johnsonii and L. plantarum were inoculated into MRSC
broth (50 mL) and incubated aerobically for 24 h at 37°C. The bacteria were then
harvested by centrifugation at 4000 g for 10 min, and re-suspended in physiological
saline. This was done in duplicate. These cell suspensions were used for encapsulation or
survival of free cells during long-term storage.
Microencapsulation of probiotics
1% (w/v) sodium alginate solution (HG400, TIC Gums, White Marsh, MD, USA)
was sterilized by autoclaving. Next, ~109 CFU mL-1 probiotic bacteria in physiological
saline (2 mL) were added to the 1% alginate solution (148 mL) and dispersed evenly by
gentle agitation. The hydrogel microbeads were formed using an encapsulator machine
(Büchi B-390 Encapsulator, Flawil, Switzerland) using a vibrating extrusion nozzle of
120 µm with standard settings (frequency 800 Hz, electrode 800 V, air pressure 300-330
mbar, amplitude 3). The liquid polymer-cell droplets were sprayed into sterile 0.10 M
calcium chloride solution (225 mL) which continuously stirred at 300 rpm. After the
mixture was exhausted, the beads were stirred continuously in calcium chloride solution
for 1 hour to complete cross-linking. Finally, the alginate microbeads (~30 mL) were
rinsed with sterile distilled water, filtered, and stored in physiological saline (50 mL) at
4°C for 10 weeks to monitor shelf-life. A sample of beads (5 mL) was reserved for
optical microscopy, scanning electron microscopy, and particle size analysis.
Particle size analysis of alginate microbeads
The particle size distribution of the calcium alginate beads was evaluated
immediately following encapsulation using a laser diffraction particle size analysis
system (Mastersizer S, Malvern Instruments, Worcestershire, UK). Samples for particle
63

size analysis (2-3 mL) were suspended in 10 mL of distilled water. Volume-based (D
[4,3]) and surface-based (D [3,2]) mean particle diameters were collected for all samples.
This was done in duplicate for all samples.
Optical Microscopy
The morphology of probiotic-filled calcium alginate microbeads was examined
immediately following encapsulation using optical microscopy to ensure beads were of
the correct size and shape. Images were captured using a microscope (C1 Digital Eclipse,
Nikon, Tokyo, Japan) with 20× and 40× objective lenses and analyzed using instrument
software (EZ CSI version 3.8, Nikon).
Scanning electron microscopy (SEM)
A bench-top scanning electron microscope (JCM-6000 NeoScope, JEOL, Tokyo,
Japan) was used to capture images of the alginate microbeads. Alginate beads were dried
for several days on aluminum foil and sputter-coated with 10 nm of gold prior to being
loaded into the SEM. Free cells were also viewed by SEM to periodically check for
contamination.
Cell enumeration of Lactobacillus cells during storage and simulated digestion
Cell viability was assessed over time using a modified drop plate method as
previously described (Herigstad et al., 2001). Briefly, 10 drops (10 µL) of each dilution
within a series (100-10-7 for free cells and 10-1-10-7 for encapsulated cells) were dropped
onto MRSC agar plates and incubated aerobically for at least 24 hours at 37°C. Dilutions
having 3-30 visible CFU per droplet were used to estimate total cell viability for each
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time point. This method was used to evaluate cell viability during refrigerated storage and
exposure to simulated digestion fluids.
To assess survival of free cells during long-term storage, cell suspension (2 mL,
prepared as described in section 2.2) were transferred to physiological saline (50 mL) and
stored at 4°C for 10 weeks. To assess survival of encapsulated cells during long-term
storage, beads (~30 mL) were stored in physiological saline (50 mL) at 4°C for 10 weeks.
Cell counts of the encapsulated cells were measured at days 0, 1, 3, 5, 7, 10, 14, 17, 28,
and then once weekly until day 80. At each of these time points, cell-containing alginate
microbeads (1 mL) was suspended in 10% (w/v) sodium citrate dihydrate solution (pH
8.2, 9 mL) and vortexed to dissolve the beads and release the cells. Serial dilutions were
prepared from this 10-1 sample. Cell counts of the free cells were taken at days 0, 1, 3, 5,
7, 10, 14, 17, 28, and then every 7 days after until day 80. Serial dilutions were prepared
from the initial sample (100).
Chemicals used in the simulated digestion were ammonium nitrate, porcine bile
extract, lipase from porcine pancreas type II, pepsin from porcine gastric mucosa, porcine
gastric mucin type II, potassium chloride, potassium citrate, potassium phosphate, sodium
DL-lactate, sodium hydroxide, uric acid sodium salt, hydrochloric acid, phosphate buffer
saline (PBS), and urea.
The artificial saliva stock solution (1 L) was prepared by stirring the following in
distilled water until dissolved: sodium chloride (1.594 g), ammonium nitrate (0.328 g),
potassium phosphate (0.636 g), potassium chloride (0.202 g), potassium citrate (0.308 g),
uric acid sodium salt (0.021 g), sodium DL-lactate (0.146 g), and urea (0.198 g). The day
prior to the simulated digestion of L. plantarum, the artificial saliva work solution was
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prepared by adding porcine gastric mucin type II (3 g) to artificial saliva stock solution
(100 mL) and stirring the solution overnight at room temperature.
The simulated gastric fluid (1 L) was prepared by stirring sodium chloride (2 g)
and 6 M hydrochloric acid (7 mL) into distilled water. On the day of the simulated
digestion experiments, the gastric fluid work solution was prepared by adding pepsin
(0.32 g) to simulated gastric fluid stock solution (100 mL) and stirred at room
temperature.
The intestinal phase stock solution (500 mL) was prepared by stirring calcium
chloride (18.375 g) and sodium chloride (109.685 g) with distilled water. The bile salt
solution was prepared 24 h before experimentation by adding bile salts (0.5357 g) to
phosphate buffer (10 mL) and stirring overnight. Approximately 45 min prior to the
intestinal phase, lipase (0.168 g) was added to phosphate buffer (7 mL) and stirred for 30
min. The simulated intestinal work solution was prepared by adding phosphate buffered
saline solution (35 mL) intestinal phase stock solution (2 mL), bile salt solution (4.7 mL),
and lipase solution (3.3 mL).
During the simulated digestion experiments, free (5 mL) and encapsulated (5 g)
Lactobacillus cells were each added to artificial saliva work solution (45 mL, pH adjusted
to 6.74-8.80), simulated gastric fluid (45 mL, pH adjusted to 2.44-2.52), and simulated
intestinal fluid (45 mL, pH adjusted to 6.85-6.95) and kept at 37°C in a shaking incubator
(MaxQ 6000, Thermo Scientific, Waltham, MA, USA) at 110 rpm. Samples (1 mL) were
taken from each of the solutions at 5, 10, 15, and 30 minutes for the salivary phase and at
5, 15, 30, 60, 90, and 120 minutes for the gastric and intestinal phases. Dilutions (100-
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10-7) were plated onto MRSC agar plates and incubated at 37°C overnight for cell
enumeration.
Statistical analysis
Particle size analysis results are shown as the mean of triplicate values. For cell
enumeration counts, the mean value of 10 replicates (drops) was used to calculate cell
counts for each free and encapsulated sample. Duplicate encapsulations were performed
for L. plantarum and L. johnsonii. Analysis of variance (ANOVA) followed by Tukey
honest significant difference test was determined using statistical analysis software
package (GraphPad Prism 7, GraphPad Software, La Jolla, CA, USA).
Results
Laser diffraction particle size analysis was used to determine the mean diameter
and particle size distribution of the Lactobacilli-containing calcium alginate microbeads
(Table B.1, Figure B.1). The diameters of the alginate beads containing encapsulated L.
johnsonii ranged from 126-188 µm (D [3,2]), while the diameters of the L. plantarumcontaining beads ranged from 208-226 µm (D [3,2]). There was no statistical difference
in the average diameters (D [3,2]) of the two replicates of beads containing L. plantarum,
as well as the beads containing L. plantarum and replicate B of the beads containing L.
johnsonii. The diameter (D [3,2]) of replicate A of the beads containing L. johnsonii was
statistically different in size. However, there was no statistically significant effect on the
storage times of the encapsulated L. plantarum and L. johnsonii at day 70 (Figure B.4).
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Table B.1:
Mean particle diameters of alginate beads containing Lactobacillus
plantarum and Lactobacillus johnsonii. Averages were determined by static light
scattering. Values are shown as volume-based (D[4,3]) and surface-based (D[3,2]) mean
± standard deviation.
Alginate Beads
L. plantarum
L. johnsonii

Replicate
1
2
1
2

D [4,3]

D [3,2]

334 ± 27a
337 ± 10a
184 ± 6b
254 ± 6c

µm
208 ± 13a
226 ± 9a
126 ± 3b
188 ± 12a

Figure B.1: Particle size distribution of alginate beads containing Lactobacillus
plantarum and Lactobacillus johnsonii. Fresh samples were analyzed by static light
scattering. Error bars represent the standard error of the mean.
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Optical microscopy was used to examine the structure of the calcium alginate
microbeads containing L. plantarum and L. johnsonii. The hydrogel microbeads were
spherical with small indentations and were ~150-350 µm in diameter for both the L.
plantarum and L. johnsonii containing beads (Figure B.2). This was consistent with the
particle size analysis data (Table B.1). The Lactobacillus cells were visibly immobilized
within the transparent hydrogel microbeads, confirming that the encapsulation was
achieved. Within the microbeads, L. plantarum cells appeared to be spread uniformly
throughout the hydrogel, while L. johnsonii cells appeared to be more aggregated.

Figure B.2: Optical microscope images of (A) alginate microbead containing
Lactobacillus plantarum (20×), (B) alginate microbead containing Lactobacillus
johnsonii (20×). Scale bars represent 100 µm.
Scanning electron microscopy (SEM) was used to visualize the morphology of the
calcium alginate beads. SEM was also used to visualize the free L. plantarum and L.
johnsonii and to check for contamination. The free L. plantarum and L. johnsonii cells
appeared consistent to their known morphologies, suggesting no contamination occurred
(Figure B.3A, B.3C). The dried beads appeared more irregular than the wet beads
visualized using optical microscopy (Figure B.2). The beads appeared to be collapsed
from their previous spherical shape due to the loss of water formerly trapped inside the
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hydrogel. The microbeads all exhibited diameters of ~150-350 µm. The surface of the
beads containing L. plantarum and L. johnsonii were similar in appearance (Figure B.3B,
B.3D).

Figure B.3: Scanning electron microscope images of (A) Lactobacillus plantarum
ATCC BAA-793 (4000×), (B) alginate bead containing L. plantarum (300×), (C)
Lactobacillus johnsonii ATCC 33200 (2000×), (D) alginate bead containing L.
johnsonii (500×). Samples were dried before sputter-coating with gold. SEM was set at
high-vacuum, 10 kV. Scale bars for (A), (B), (C), and (D) represent 5, 100, 10, and 50
µm respectively.
Cell viabilities of free and encapsulated L. plantarum and L. johnsonii were
compared over time during refrigerated storage (Figure B.4, Table B.2). Free L. johnsonii
cells showed the shortest period of viability remaining consistently around 10 logs CFU
until day 10 and then sharply dropped after day 17, reaching undetectable levels by day
31. Encapsulated L. johnsonii cells maintained high viability, having 9.09 logs CFU after
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56 days of storage. This was only a 1 log decrease from the initial encapsulation of L.
johnsonii compared to a 10 log reduction over 31 days for the free L. johnsonii cells.
Thus, encapsulation of L. johnsonii significantly extended cell viability during long-term
storage.

Figure B.4: Survival of free and encapsulated Lactobacillus plantarum and
Lactobacillus johnsonii during refrigerated storage. Cell counts are based on samples
drop-plated on MRSC agar and incubating at 37°C aerobically. Error bars indicate the
standard error of the mean.
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Table B.2:
Viability of free and encapsulated Lactobacillus plantarum and
Lactobacillus johnsonii during refrigerated storage. Cell counts are based on samples
drop-plated on MRSC agar and incubating at 37°C aerobically. Values are shown as
mean ± standard error of replicate counts. Means within each column followed by the
same lowercase letters are not significantly different (p > 0.05) from each other. Means
within each row followed by the same uppercase letters are not significantly different (p
> 0.05) from each other.
Lactobacillus plantarum
Lactobacillus johnsonii
Time
Free
Encapsulated
Free
Encapsulated
log CFU
Day 0
10.9±0.148aA
10.2±0.0757abA
10.6±0.0239aA
10.1±0.145abA
Day 1
10.9±0.0965aA
10.6±0.0578aA
10.5±0.186aA
10.4±0.0540aA
aA
aA
aA
Day 3
10.9±0.118
10.7±0.0949
10.5±0.0658
9.62±0.432abA
Day 5
10.9±0.0982aA
10.7±0.0481abA
10.4±0.0406aA
10.3±0.0408abA
aA
aA
aA
Week 1
10.8±0.0822
10.7±0.0576
10.1±0.0513
9.98±0.106abA
Day 10
10.9±0.0390aA
10.7±0.0489aA
10.1±0.0292aA
9.92±0.205abA
aA
aA
aB
Week 2
10.8±0.0811
10.7±0.0781
9.04±0.557
8.99±1.26abA
Week 3
10.7±0.164aA
10.5±0.0871abAB 8.91±0.0630aB
10.0±0.204abA
Week 4
10.6±0.0833aA
10.6±0.164abA
3.39±0.702bB
9.65±0.267abA
aA
abA
cB
Week 5
10.5±0.0892
10.2±0.333
ND
9.41±0.318abA
Week 6
10.6±0.317aA
9.71±0.650abA
9.22±0.530abA
abA
abA
Week 7
9.52±0.719
9.57±0.742
9.27±0.390abA
Week 8
8.61±0.252bcA
9.40±0.947abA
9.09±0.158abA
bcA
abA
Week 9
8.01±0.159
9.14±0.905
8.95±0.178abA
Week 10
7.86±0.210bcA
8.93±1.23abA
8.78±0.0587abA
Week 11
7.50±0.379cA
8.81±1.12bA
8.65±0.206abA
cA
bA
Week 12
7.36±0.336
8.62±1.14
8.47±0.0194bA

Free and encapsulated L. plantarum both maintained high viability over the 12
week storage period; there was no statistical difference in cell viability between free and
encapsulated L. plantarum during long-term storage. By day 70, average log CFU of the
encapsulated cells was 2-log higher than free cells (not statistically significant).
While encapsulating L. plantarum did not significantly extend shelf life during
storage, survivability in simulated digestion fluids differed between free and encapsulated
cells (Table B.3). Encapsulated L. plantarum was 4 log CFU higher than free L.
plantarum after 60 minutes exposure to gastric phase. When exposed to intestinal phase,
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Table B.3:
Simulated digestion of free and encapsulated Lactobacillus plantarum and Lactobacillus johnsonii cells. Counts
based on samples drop-plated on MRSC agar and incubated at 37°C aerobically. Values are shown as mean cell number ± standard
error of duplicate results. Within each treatment, means within each column followed by the same letters are not significantly different
(p > 0.05) from each other.
L. plantarum
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pH
Time (min)
0
5
10
15
30
60
90
120
L. johnsonii
pH
Time (min)
0
5
10
15
30
60
90
120

Salivary
6.74-6.80

Free cells
Gastric
2.44-2.52

9.86±0.0241a
9.74±0.125a
9.77±0.0541a
9.26±0.479a
9.82±0.0372a
-

9.86±0.0241a
9.09±1.68a
6.88±2.83ab
5.00±4.33bc
2.96±2.96cd
NDd
NDd

Salivary
6.83-6.97

Free cells
Gastric
2.55-2.66

8.15±1.53a
7.94±1.60a
7.96±1.56a
7.52±1.06a
8.00±1.60a
-

8.15±1.53a
8.10±1.70a
8.06±1.73a
<7.07±2.37a
>6.28±1.90a
>7.08±1.09a
>6.47±0.709a

Encapsulated cells
Intestinal
Salivary
Gastric
Intestinal
6.96-6.98
6.72-6.89
2.44-2.48
6.85-6.95
log CFU
9.86±0.0241a 10.1±0.138a
10.1±0.138a
10.1±0.138a
8.83±0.471a
9.98±0.413a
9.97±0.159a
9.35±0.336a
a
10.3±0.0266
8.64±0.220a
9.19±1.07a
9.42±0.497a
9.39±0.470a
8.64±0.283a
9.71±0.543a
9.26±0.156a
8.69±1.16a
a
a
8.42±0.664
7.01±1.05
9.20±0.438a
8.51±0.551a
0.570±0.570b 9.27±0.541a
a
8.35±0.473
0.855±0.855b 9.26±0.594a
Intestinal
Salivary
7.02-7.08
6.85-6.89
log CFU
8.15±1.53a
7.96±1.61a
b
ND
8.09±1.75a
8.09±1.74a
b
ND
8.01±1.58a
NDb
8.17±1.64a
b
ND
NDb
b
ND
-

Encapsulated cells
Gastric
Intestinal
2.48-2.59
7.08-7.14
7.96±1.61a
8.03±1.48a
8.30±1.82a
7.98±1.57a
>7.76±1.41a
>7.06±1.12a
>7.06±1.12a

7.96±1.61a
<5.33±1.63ab
<5.79±2.09ab
<3.87±0.175b
<5.75±2.05ab
<5.81±2.11ab
<5.85±2.15ab

free L. plantarum only decreased by 1.5 log CFU, and encapsulated L. plantarum
decreased by 0.84 log CFU after 120 minutes.
Encapsulating L. johnsonii in alginate did not significantly improve cell viability
when exposed to the three simulated digestion phases. Indeed, effectively no change in
viability was seen for both free and encapsulated cell in salivary phase, similar to that of
L. plantarum. Free and encapsulated L. johnsonii cell viability decreased when exposed
to gastric phase, but not as drastically as L. plantarum. Free L. johnsonii decreased 1.1
log CFU in 30 minutes and maintained high viability over the 120 minutes time period.
Similarly, viability of encapsulated L. johnsonii decreased 0.9 log over 90 minutes.
Unlike L. plantarum samples, both free and encapsulated L. johnsonii rapidly decreased
in viability under exposure to simulated intestinal phase, suggesting high sensitivity to
bile salts and lipase.
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